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 The effects of advanced paternal age have received little attention in the past. 
However, recent data from multiple groups suggesting an association between advanced 
paternal age and various disorders in the offspring have sparked a great deal of interest. 
Specifically, offspring of older fathers have an increased risk of autism, bipolar disorder, 
and schizophrenia among other issues. Further fueling this interest is the striking trend of 
delayed parenthood in developed countries, likely a result of socioeconomic pressures 
and increasing divorce rates with subsequent remarriage. Increased interest in the 
“paternal age effect” has driven some private tissue banks to promote cryopreservation of 
sperm at a young age to avoid the detrimental impacts of aging. Taken together, there is a 
great need for further investigation into this phenomenon. 
 Although there is solid epidemiological evidence to substantiate the impacts of 
advanced paternal age on the offspring, the etiological mechanisms that drive this process 
remain poorly defined. Among the most plausible contributing factors to the increased 
incidence of various diseases in the offspring of older fathers are age-associated 
alterations to the sperm epigenome. Specifically, sperm DNA methylation perturbations 
may have the capacity to affect offspring phenotype through transcription 
inhibition/activation but have yet to be explored in the context of advancing age.   
  To investigate age-associated sperm DNA methylation alterations, we have 
analyzed sperm from 17 donors who collected samples between 9 and 19 years apart. 
 DNA methylation was analyzed in all samples at both the global and cytosine phosphate 
guanine (CpG) level. The results indicate that global sperm DNA methylation increases 
with age while regional alterations are strongly biased toward hypomethylation, a finding 
in stark contrast to somatic cell age-associated methylation alterations. Intriguingly, many 
of the genes affected by regional methylation alteration have been previously suggested 
to be associated with many types of neuropsychiatric disorders, including schizophrenia, 
bipolar disorder, developmental delay, personality disorders, and autism.  
 These data provide the first direct evidence that age-associated epigenetic 
alterations to the sperm represent a plausible mechanism for the increased incidence of 
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Abstract
Recent work in the field of male fertility has yielded significant increases in our understanding of the sperm epigenome and its potential
role in embryonic development. These new findings have enabled a broad classification of a normal epigenetic state in the male gamete
and have provided insight into the possible etiologies of some idiopathic male infertility cases. Histone retention and modification,
protamine incorporation into the chromatin, DNA methylation, and spermatozoal RNA transcripts appear to play important roles in the
epigenetic state of mature sperm. These epigenetic factors may reveal a historical record of spermatogenesis, portend future functions in
embryogenesis, and help to elucidate mechanism of pluripotency. In contrast to the once held dogma regarding the importance of the
paternal epigenome, the unique epigenetic landscape in sperm appears to serve more than the gamete itself and is likely influential in the
developing embryo. In fact, growing evidence suggests that mature sperm provide appropriate epigenetic marks that drive specific genes
toward activation and contribute to the pluripotent state of the embryonic cells. Although not definitive, the current literature provides
evidence for the role of the sperm epigenome in the embryo. Future work must be focused on the characterization of epigenetic
abnormalities commonly found in individuals with compromised fertility to further establish this role. Additionally, studies should target
the effects of environment and aging on the sperm epigenetic program and subsequent fertility loss to determine the etiology of aberrant
epigenetic profiles.
Reproduction (2012) 143 727–734
Introduction
The sperm epigenetic program is unique and tailored to
meet the needs of this highly specialized cell. Chromatin
changes in sperm contribute to virtually every function
that the male gamete must perform throughout sperma-
togenesis and in the mature cell. One requirement of
sperm is that of transportation through both the female
and male reproductive tracts, which demands a highly
motile cell type. The unique nuclear protein landscape
in sperm creates a chromatin structure that is between six
and 20 times more dense than nucleosome-bound DNA,
ultimately resulting in tightly condensed nucleus
(Ward & Coffey 1991, Balhorn 2007). The compacted
sperm head is proposed to provide enhanced motility
and protection from DNA damage in a cell type that
lacks robust repair mechanisms (Oliva & Dixon 1991).
This is particularly important as sperm encounter many
harsh environments during transport through the female
reproductive tract.
The unique chromatin structure in sperm is essential
for the safe delivery of paternal DNA to the oocyte, but
the requisite replacement of canonical histones with
sperm-specific protamine proteins has called into
question the utility of the paternal epigenome in
embryonic development. The stepwise transition of
sperm nuclear proteins first involves the replacement of
canonical histones with transition proteins. Next, two
isoforms of protamine proteins, protamine 1 (P1) and P2,
take the place of transition proteins in the sperm
chromatin. The ratio of incorporated P1 and P2 is tightly
regulated at w1:1 ratio in the mature sperm (Balhorn
et al. 1988, Hecht 1990, Oliva & Dixon 1990, Dadoune
1995). Aberrations in this ratio have been correlated with
general infertility and poor fertilization ability (Aoki et al.
2005, 2006, Zhang et al. 2006). The protamination of
sperm chromatin provides the compaction necessary for
safe delivery to the oocyte but removes histones, which
are capable of eliciting gene activation or silencing via
tail modifications (methylation, acetylation, etc.). In
effect, protamination removes a potentially informative
epigenetic layer from the paternal chromatin, leading to
the previously held belief that sperm are incompetent to
q 2012 Society for Reproduction and Fertility DOI: 10.1530/REP-11-0450




drive epigenetic changes in the embryo and suggesting
that their utility is found only in the delivery of an
undamaged DNA blueprint. However, recent data
challenges this dogma.
It is known that the replacement of histone with
protamine is incomplete, with about 5–15% of the
chromatin remaining nucleosome-bound (Tanphaichitr
et al. 1978, Wykes & Krawetz 2003). Interestingly, this
incomplete replacement was found to be programmatic
and not simply a result of inefficient machinery,
suggesting that retained histones may contain modifi-
cations that play a role in epigenetic regulation
(Arpanahi et al. 2009, Hammoud et al. 2009). In
known fertile patients, histone retention is found at the
promoters of genes important in the embryo including
developmental gene promoters, microRNA clusters, and
imprinted loci, suggesting that the nucleosome retention
is programmatic in nature (Hammoud et al. 2009). Taken
together, these data suggest that the limited view of
the sperm epigenome in developmental regulation is
incomplete.
The growing evidence in support of the hypothesis that
the paternal epigenome plays an important role in the
developing embryo is not limited to nucleosome
retention data. Recent studies analyzing sperm DNA
methylation, histone modifications, and spermatozoal
RNA transcripts further establish the role of the sperm
epigenetic program in the developing embryo. This
review will describe the current literature regarding the
paternal epigenome and its influence on embryogenesis
and will additionally address critical future research
directions.
DNA methylation
DNA methylation is a common regulatory mark found
on the 5 carbon of cytosine residues (5-mC) at cytosine–
phosphate–guanine dinucleotides (CpGs; Fig. 1), which
exert strong epigenetic regulation in many cell types
(Portela & Esteller 2010). DNAmethylation is essential in
genomic imprinting, gene expression regulation,
X chromosomal inactivation, and embryonic develop-
ment (Jaenisch & Jahner 1984, Surani 1998, Ng & Bird
1999). This epigenetic mark can activate or repress gene
transcription at specific sites based on the methylation
levels at promoter regions. Hypermethylation at
promoters blocks access of transcriptional machinery
and thus inhibits gene expression. Conversely, hypo-
methylation facilitates gene activation as a result of
increased accessibility of DNA by polymerase (Fig. 2).
The regulation of DNA methylation is essential to
normal cell function in somatic cells, gametes, and the
embryo (Jaenisch & Jahner 1984, Surani 1998, Ng & Bird
1999). The DNA methyltransferase (DNMT) family of
proteins helps to facilitate de novo methylation and
methylation maintenance (Eden & Cedar 1994). The
enzymes directly responsible for de novo methylation
include DNMT3A (DNMT3a), DNMT3B (DNMT3b),
and DNMT3L (DNMT3l). Both DNMT3A and DNMT3B
contain catalytic domains, which allow them to directly
lay down new methylation marks. DNMT3L is essential
in directing the proper placement of marks by working in
concert with DNMT3A and DNMT3B (Okano et al.
1999). Once methylation marks have been established,
DNMT1 maintains those marks through cell division
(Bestor 1992, Lei et al. 1996).
The importance of DNA methylation has been
demonstrated globally, regionally, and at the single
locus level in both humans and animal models. Of
great value in the effort to increase our understanding of
the role of DNAmethylation is recent data describing the
human sperm methylome, which provides a general
classification of a ‘normal’ methylation status at 96% of
genomic CpGs (Molaro et al. 2011). Recent data
demonstrate that aberrant methylation of promoters for
specific genes (e.g. DAZL andMTHFR) and general gene
classes, such as imprinted loci, are strongly associated






Figure 1 Epigenetic modifications (both histone modifications and DNA methylation) commonly found in sperm. Depicted are histone tail
modifications (methylation and acetylation) as well as 5-methylcytosine (5-mC) and the demethylation intermediate, 5-hydroxymethylcytosine
(5-hmC). Each modification is believed to play a regulatory role in gene expression.
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(Navarro-Costa et al. 2011, Pacheco et al. 2011, Wu
et al. 2011). Additionally, El Hajj et al. (2011) suggest
that improper methylation of repetitive elements may be
linked to recurrent pregnancy loss. Methylation abnorm-
alities at the promoter of CREM were seen in a subset of
patients with coinciding protamine ratio abnormalities
as well as in patients presenting with various forms of
male factor infertility (Nanassy & Carrell 2011a, 2011b).
Additionally, Benchaib et al. (2005) reported that among
IVF patients, global sperm DNA hypomethylation is
correlated with poor pregnancy outcomes. Interestingly,
the data revealing the importance of DNA methylation
are not only limited to studies on patients with reduced
fertility but has also been suggested on known fertile
donors. These data reveal an epigenetic landscape that
appears programmed for use in the embryo with
hypomethylated DNA at developmental promoters
(Hammoud et al. 2009). Taken together, these data
suggest that DNA methylation may play an essential role
in both the sperm and the embryo.
Multiple targeted studies have been performed in
animal models to establish a clear role of DNA
methylation in the sperm and embryo. Knockouts and
mutations of Dnmt1 in mice caused severe global
hypomethylation resulting in biallelic expression at
imprinted differentially methylated regions (DMRs),
transcription of retrotransposons, loss of chromosomal
inactivation, retarded gestational growth, and, in turn,
embryo lethality (Li et al. 1992, Panning & Jaenisch
1996, Walsh et al. 1998). Conditional knockouts
of DNMT3A and DNMT3L were hypomethylated at
imprinted DMRs and resulted in severe decreases in
spermatogenesis with DNMT3L loss also resulting
in global decreases in methylation (Kaneda et al. 2004,
La Salle et al. 2007). The loss of DNMT3B did not result
in severe phenotypes, suggesting that there is redun-
dancy in its function. However, the loss of DNMT3B
did prove to affect Rasgrf1 promoter methylation, which
was not seen in the DNMT3A conditional knockout
(Kaneda et al. 2004, Kato et al. 2007). These data suggest
that there are regions where DNMT3A and DNMT3B
act independently, as well as regions of redundancy.
In addition to studies using targeted genetic
approaches in the study of DNA methylation are those
using 5-azacytidine and 5-aza-2-deoxycytidine, both
potent DNA methylation inhibitors (Egger et al. 2004).
Short-term 5-aza-2-deoxycytidine exposure in neonatal
male mice reduced overall fertility status by halting
spermatogenic differentiation (Raman & Narayan 1995).





























Figure 2 This figure depicts epigenetic marks that contribute to gene activation or inactivation, as well as bivalent modifications. Epigenetic
regulators that promote gene transcription include DNA hypomethylation, histone H2B ubiquitination, H3 acetylation, H3K4 methylation, and H4
acetylation. Marks that tend to inhibit transcription include DNA hypermethylation, H2A ubiquitination, H3K9 methylation, and H3K27
methylation. Bivalent histone modifications (H3K27methylation and H3K4methylation) and enrichment of 5-hmC at gene promoters appear to be a
hallmark of pluripotency.
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mating had decreases in fertility and increased incidence
of embryomortality (Seifertova et al. 1976). Additionally,
5-aza-2-deoxycytidine treatment in both mouse and rat
resulted in decreased fertilization rates and/or increased
preimplantation loss (Doerksen & Trasler 1996, Kelly
et al. 2003, Oakes et al. 2007). It should be noted that
while global demethylation is observed in the sperm
with this treatment, the effects on embryogenesis may
ultimately be a result of the cytotoxic effects of the drug
and not solely the result of methylation defects (Oakes
et al. 2007).
Along with the current interest in CpG methylation,
recent data has suggested that intermediates formed
during DNA demethylation may be important epigenetic
regulators. Most prominent among these intermediates is
5-hydroxymethylcytosine (5-hmC; Fig. 1). This DNA
modification is formed via the TET family of proteins
(Tahiliani et al. 2009) just before complete removal of
methylation marks. Because it is an intermediate, 5-hmC
can achieve full demethylation more quickly than
5-methylcytosine, and as a result, gene promoters with
enriched 5-hmC are considered easier to activate and
thus may play a role in epigenetic regulation (Fig. 2;
Pastor et al. 2011). Interestingly, recent work from Pastor
et al. (2011) has revealed an enrichment pattern of
5-hmC at poised genes in the stem cell. This unique
localization suggests that 5-hmC has utility in the
embryonic stem cell and possibly the epigenome of
multiple other cells types. As nucleosome retention was
found at similar poised loci in sperm (Hammoud et al.
2009), identification of regional 5-hmC enrichment must
be analyzed in the male gamete. These data suggest that
5-hmC may have real impacts on the epigenome and
must be a focus of future studies to fully elucidate its
regulatory role.
The current literature provides strong evidence for the
importance of appropriate DNA methylation. This
essential epigenetic mark has tremendous utility in the
maintenance of gene activation and repression. Inap-
propriate methylation clearly results in abnormal
phenotypes and as such, efforts should be made to
determine the etiology of these aberrant profiles so that
proper preventative steps and treatments can be
established.
Retained histones, their modifications, and
spermatozoal RNA transcripts
One of the most unique epigenetic features in the male
gamete is the replacement of DNA-bound histones with
protamines. As mentioned earlier, this protamination
creates a highly condensed nuclear structure that helps
to enable proper motility and protects DNA from
damage. Although incorporation of this unique, sperm-
specific protein results in a quiescent chromatin
structure, some regions retain histones and their
associated modifications. Recent studies have found
this nucleosome retention to be programmatic and not a
result of random distribution (Arpanahi et al. 2009,
Hammoud et al. 2009). The mechanism that directs this
selective nucleosome retention remains largely unchar-
acterized, but there is evidence to suggest a role for RNA
transcripts in the process (Rassoulzadegan et al. 2006,
Dadoune 2009). It appears that spermatozoal RNA
transcripts are capable of inhibiting the protamination
process and maintaining a histone-bound chromatin
structure (Miller et al. 2005). RNA transcripts colocalize
with nucleosome-bound chromatin near the nuclear
envelope in the mature sperm, as is the case with
the insulin-like growth factor 2 (IGF2) locus (Wykes &
Krawetz 2003, Miller et al. 2005). There remains
controversy in the role of RNA in this process, but the
colocalization with regions of retained nucleosomes
does provide a possible mechanism to explain the
regulation of histone retention. In theory, this selective
retention in sperm could allow for targeted gene
activation or silencing in the embryo.
Multiple histone variants found in sperm play an
essential role throughout spermatogenesis as well as
in the mature spermatozoa. Among these, important
nuclear proteins are histone 2A and B (H2A and H2B),
histone 3 (H3), histone 4 (H4), and the testes variant
(tH2B) (Gatewood et al. 1990, Jenuwein & Allis 2001,
Fenic et al. 2004, Baarends et al. 2005, Zhu et al. 2005,
Okada et al. 2007). Histone proteins have the distinct
capability of driving epigenetic changes based on tail
modifications. As a result, those histones retained
through the protamination process are likely competent
to exert similar regulatory effects. Targeted gene
activation or silencing in many different cell types can
be driven by these tail modifications found at lysine (K)
and serine (S) residues of histones. The main forms of
modifications in sperm include methylation, acetylation,
ubiquitination, and phosphorylation, which can act
alone or in concert to ensure the proper state of
activation or suppression at any given gene or gene
promoter (Fig. 1). H3K4 methylation, H3 and H4
acetylation, and H2B ubiquitination drive the genes
toward activation while H3K9 and H3K27 methylation,
deacetylation at H3 and H4, and H2A ubiquitination
enrichment support gene silencing (Fig. 2; Jenuwein &
Allis 2001, Lachner & Jenuwein 2002, Baarends et al.
2005, Zhu et al. 2005). These modifications are
established and regulated by a variety of enzymes. The
histone methyltransferase and demethylase family of
proteins catalyze methylation and demethylation
(Lachner & Jenuwein 2002). Acetylation establishment
and removal are regulated by histone acetyltransferase
and deacetylase respectively (Jenuwein & Allis 2001).
As a result of protamination, few histones remain
to function as epigenetic regulators. However, as
previously mentioned, the few loci that have been
shown to retain histones in the mature sperm are known
730 T G Jenkins and D T Carrell
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 to be important in developmental processes (Hammoud
et al. 2009). This suggests that histones in these select
regions are able to provide some degree of retained
regulatory competence via histone tail modifications.
Indeed, recent studies have implicated aberrant histone
methylation and/or acetylation in the mature sperm in
various forms of infertility. Loss-of-function mutation
of JmjC-domain-containing-histone demethylase 2A
(JHDM2A), an enzyme with known H3K9 demethylase
activity, revealed decreased transcription of transition
protein 1 and P1 during spermatogenesis (Okada et al.
2007). Additional studies have demonstrated that varied
degrees of infertility, including sterility, are correlated
with perturbations in histone methylation (Lee et al.
2005, Glaser et al. 2009). Deacetylase inhibitors, such as
trichostatin-A, have been used in the study of histone
modification and epigenetic regulation in mice. Fenic
et al. (2004, 2008) demonstrated that s.c. injection of
trichostatin-A in male mice resulted in a dose-dependent
decrease in spermatogenesis and testis weight as well as
decrease in histone deacetylase activity and subsequent
alterations in histone acetylation. On amore broad level,
recent work from Hammoud et al. (2011) has shown that
histone retention is not programmatic but random in
some patients with two different classes of infertility.
A decreased enrichment ofH3K4meorH3K27meat select
regions important to development was also identified.
These studies provide additional evidence that suggests
a regulatory role of histone modifications in sperm.
In normal human sperm, histone modifications
and their enrichment patterns suggest a highly
regulated epigenetic landscape. H3K4 dimethylation
(H3K4me2) and H3K4 trimethylation (H3K4me3) were
found enriched at developmental promoters important
in the embryo. Additionally, H3K27 trimethylation
(H3K27me3) is enriched at gene promoters that are
silenced in the early embryo (Hammoud et al. 2009).
Further data describe a pluripotent-like state that some
genomic regions important to the developmental
program show in both human and mouse (Hammoud
et al. 2009, Brykczynska et al. 2010). In these regions,
bivalent histone modifications, H3K4me3 and
H3K27me3, reflect marks found in stem cells (Fig. 2).
These findings provide additional evidence that the
paternal epigenome may be needed for proper embryo-
nic development and may additionally contribute to the
pluripotent state of embryonic stem cells.
Taken together, these data suggest a role of the
paternal epigenome in early embryonic development.
Nucleosome retention provides additional epigenetic
competence to the paternal chromatin that was once
considered to be void of such marks. It appears likely
that histone retention and histone modifications are key
to normal sperm function and ultimately normal
embryogenesis. As our understanding of the role of
histones and their modifications in sperm increase, we
will be able to better classify, diagnose, and treat male
factor infertility.
Conclusions and future directions
The role of the paternal epigenome in the embryo has
long been considered to exert only limited influence on
development. However, the recent literature described
in this review provides evidence that the unique
epigenetic landscape in sperm may play a larger role
in development than previously believed. From these
data, it is evident that proper establishment and
maintenance of the paternal epigenetic program is
associated with appropriate gamete and embryonic
development, disruption of which is associated with
varied degrees of infertility. While recent studies have
been key in opening this relatively new area of study,
many questions remain unanswered.
Further research is required to fully elucidate the
paternal regulatory control in the embryo. One key will
be to further investigate the epigenetic profiles of various
classifications of infertility along with embryo quality
data. Special caution must be taken to ensure that proper
patient classification is used to ensure that results are
clearly attributable to unique and definable etiologies
as opposed to infertility in general. This will allow
a determination of direct correlations, and possibly
causation, to specific infertility classes.
In addition to observing aberrant epigenetic profiles
common among specific populations of infertile men,
the etiologies of these various abnormalities must be
investigated. There are many likely candidates that may
cause epigenetic alterations in sperm and resultant
abnormal embryogenesis, the most prominent of which
are environmental toxins and aging. Studies have
evaluated various environmental agents and their effects
on male fertility in general, but few have analyzed
specific epigenetic alterations that may be occurring as
a result of exposure. However, there is precedence for
environmental impacts on the paternal epigenetic land-
scape. Recent studies provide intriguing evidence for the
effects of heavy metals on sperm nuclear proteins,
specifically P2. Quintanilla-Vega et al. (2000a, 2000b)
reported that lead binds to P2 and inhibits its DNA
binding, ultimately affecting chromatin compaction.
Yauk et al. (2008) found that mice exposed to ambient
air pollution had global DNA hypermethylation
compared with animals housed with high-efficiency
particulate arresting (HEPA)-filtered air. Additionally,
exposure to endocrine disrupters has also been shown
to disrupt heritable germ cell epigenetics (Anway &
Skinner 2008). These data clearly suggest that environ-
mental agents can affect sperm epigenetics. Environ-
mental toxins must be targeted in future studies
analyzing the etiology of epigenetic alterations in
sperm to aid improvement in diagnostic and treatment
approaches in men who present with infertility.
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In addition to the effects of the environment on the
sperm epigenome, there is also increasing concern
regarding the effects of advanced paternal age on
epigenetic alterations seen in male gametes. It is well
established that advanced maternal age is associated
with poor pregnancy outcomes, mainly as a result of
increased incidence of chromosomal nondisjunction
(Eichenlaub-Ritter 1998). Conversely, paternal aging has
long been considered of little consequence in the
development of functional sperm capable of generating
normal offspring. However, the available data suggest
that there are likely aberrations occurring in the sperm of
aging males that may affect offspring. Recent work from
Flatscher-Bader et al. (2011) has shown that copy
number variations are more common in the offspring of
older male mice than from younger fathers. Although the
idea of epigenetic alterations occurring as a result of
aging in males is still controversial, recent studies have
yielded interesting data on this front as well. Changes in
gene expression and chromatin compaction in sperm
and testes tissue of older males have been described in
recent studies while contradictory data have been
presented in other studies (Wyrobek et al. 2006,
Zubkova & Robaire 2006, Kokkinaki et al. 2010).
Despite some controversy when taken together, these
data still appear to suggest that advanced paternal aging
may be accompanied by some degree of epigenetic
alterations in the sperm. These changes are, however,
poorly characterized.
It is evident that the paternal epigenome plays a role in
sperm quality and likely in embryonic development;
however, many unanswered questions remain. It will be
critical for future studies to focus on common epigenetic
abnormalities found in specific classes of infertility.
Additionally, research should focus on the etiologies of
such abnormalities. The effect of environmental
exposures and aging are two major topics that have yet
to be fully addressed in relation to the genesis of an
aberrant sperm epigenetic program. As we learn more
about the true effects of epigenetic alterations in sperm,
how they arise and how they affect fecundity, we will be
more capable of addressing the growing issue of male
factor infertility in prevention, diagnosis, and treatment.
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 3.1  Introduction 
 Advanced paternal age has become a heavily 
investigated topic recently as a result of multiple 
studies demonstrating ties between advanced 
paternal age and various offspring abnormalities. 
Further contributing to the increasing interest in 
the role of advanced paternal age in reproduction 
is the trend of delayed parentage believed to be a 
result of socioeconomic pressures in developed 
countries  [ 1 ] . Though this trend is justi fi ed by 
increasing life expectancies in both sexes, 
advanced paternal age signi fi cantly affects gen-
eral semen parameters and sperm quality that 
ultimately alters fecundity and may additionally 
affect offspring health. While many couples con-
sider the risks associated with advanced maternal 
age in family planning decisions, very little 
thought is given to the age of male partners. As a 
result, it is important that physicians consulting 
couples with an aged male partner have the avail-
able data to help patients make well-informed 
family planning decisions based on the risks 
associated with advanced paternal age. This 
chapter will outline what is currently known 
regarding the effects of paternal age on fecundity 
and will also discuss the associations between 
advanced paternal age and the offspring’s disease 
risk. These effects, based on current data are 
summarized in Table  3.1 . 
 3.2  Delayed Parenthood 
 In recent history, the age of parenthood for both 
males and females has steadily increased in many 
developed countries. This trend is believed to be 
associated with increased life expectancy, socio-
economic pressures, and divorce rates with subse-
quent remarriage at older ages  [ 2 ] . During a 
10-year span (1993–2003) in Great Britain, the 
percent of fathers who were in the age range of 
35–54 increased from 25 % of total births to 40 %. 
Associated with this trend was a decrease in the 
number of births to fathers less than 35 years of 
age from 74 % of total births to only 60 %  [ 3 ] . In 
Australia, over two decades (1988–2008), the 
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average age of fathers has increased by approxi-
mately 3 years  [ 4 ] . Similarly, the average age of 
fathers in Germany increased by 2 years over a 
10-year period  [ 2 ] . Similar trends can be found in 
the United States and many other developed coun-
tries. As average paternal age continues to increase 
in many countries it is becoming increasingly 
important to characterize the potential conse-
quences of advanced paternal age on fertility and 
offspring health. 
 3.3  Age-Related Changes in Sperm 
Quality 
 With advancing male age, a number of changes 
occur to sperm and semen that can impact fertility 
status or increase the risk of disease transmission 
to offspring. These changes include declines in 
some semen parameters, increased sperm DNA 
damage, genetic changes in sperm resulting from 
mitotic or meiotic errors or errors that arise dur-
ing DNA replication, and epigenetic changes to 
sperm DNA. These changes are discussed below. 
 3.3.1  Changes in Semen Parameters 
 Unlike females, who are born with a  fi nite number 
of gametes that are generally exhausted between 
the age of 45 and 55 years, coincident with meno-
pause, men continue to produce sperm through-
out their lives. While spermatogenesis continues 
well into old age, some semen parameters do 
decline as men age. Numerous studies have eval-
uated the effects of male age on semen parame-
ters, but shortcomings of some of the individual 
studies include small sample size and failure to 
control for potentially confounding factors. For 
this reason there exists a signi fi cant degree of dis-
cordance between studies, making the reliable 
estimate of age effects dif fi cult to quantify. 
However, a thorough review of the literature from 
1980 to 1999 by Kidd et al. evaluated the effect 
of age on semen parameters and concluded that 
there is general agreement among studies that 
semen volume, sperm motility, and proportion of 
morphologically normal sperm all decline with 
advancing age  [ 5 ] . These conclusions were cor-
roborated by more recent literature reviews and 
carefully controlled primary research  [ 6– 8 ] . 
 From the available literature, it can be inferred 
that semen volume signi fi cantly decreases with 
age, with a decline of 3–22 % from age 30 to age 
50  [ 5,  8 ] . Similarly, a 3–37 % decrease in sperm 
motility is estimated to occur over the same 
period, as indicated in several studies  [ 5,  8 ] . 
Finally, the best estimates for declines in normal 
sperm morphology indicate a decrease of 4–22 % 
between the ages of 30 and 50  [ 5,  8 ] . The data 
regarding changes in sperm concentration with 
age are less conclusive, and total sperm count has 
rarely been evaluated. Of more than 20 studies 
that evaluated the effect of male age on sperm 
concentration, there is essentially an even split 
between studies that report a decline, those that 
report no age effect, and those that report increased 
 Table 3.1  The effects of advanced paternal age on semen 
parameters and offspring disease risk 
 Parameter  Effect 
 Semen parameters 
 Semen volume  ↓ 
 Sperm count  ↓? 
 Sperm motility  ↓ 
 Sperm morphology 
 ↓ 
 Genetic/epigenetic 
 DNA damage 
 ↑ 
 Aneuploidy rates 
 Sex chromosomes 
 ↑ 
 Autosomes  ~ 
 Mutations 
 ↑ 
 Telomere length 
 ↑ 
 Chromatin packaging 
 D 
 Global methylation 
 D 
 Pregnancy rate 






 Offspring disease risk 
 Autosomal dominant disorders 
 ↑ 











 Neuropsychiatric disorders 
 ↑ 
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sperm concentrations with advancing age  [ 5,  8 ] . 
As semen volume signi fi cantly declines with age, 
if spermatogenic output remained constant, then 
sperm concentration would necessarily increase 
in older men. A recent study of 1,174 men age 45 
and older reported a non-signi fi cant increase in 
sperm concentration with age, and a signi fi cant 
decline in total sperm count with advancing age 
in men between the ages of 45 and 80  [ 9 ] . 
 While the consensus based on large datasets is 
that semen volume, sperm motility, and normal 
sperm morphology decrease with advancing age, 
the decreases are generally modest. Moreover, 
the number of confounding variables such as life-
style factors, environmental in fl uences, health 
status, abstinence periods, and others make it 
nearly impossible to identify the age-associated 
causes that are directly responsible for these 
declines. 
 3.3.2  Genetic Changes 
 The molecular hallmarks of aging throughout the 
body include increased oxidative damage, 
increased aneuploidy rates and chromosomal rear-
rangements, the accumulation of mutations within 
the genome, and telomere shortening  [ 10,  11 ] . 
Sperm are particularly prone to many of these 
changes due to the high rate of cell division rela-
tive to most other cells types in the body. However, 
unlike telomere attrition that occurs in the majority 
of other cell types, the telomeres length in sperm 
actually increases with age. Genetic changes to 
sperm are discussed in the following section. 
 3.3.2.1  DNA Damage 
 Numerous studies have reported an age-related 
increase in sperm DNA damage  [ 12– 16 ] . The 
increase in DNA fragmentation index (DFI) is 
marked, with a nearly fourfold increase in men 
age 60–80 compared with men age 20–29 
reported in one study  [ 14 ] . In a large study of 
1,125 men from infertile couples, DFI more than 
doubled in men over the age of 45 compared with 
men aged 30 and younger  [ 16 ] . The mechanisms 
responsible for increased sperm DNA damage in 
older men are not completely characterized, but 
increased reactive oxygen species (ROS)  [ 17 ] , 
coupled with the insuf fi ciency of DNA repair and 
apoptotic machinery, have been proposed  [ 18 ] . 
 3.3.2.2  Aneuploidy Rates 
 The increase in gamete aneuploidy rates in 
women with advancing age is well documented 
and dramatic. It is estimated that about 20 % of 
human oocytes are aneuploid, and the incidence 
has been reported to be as high as 60 %, with a 
sharp increase in the decade preceding meno-
pause  [ 19– 21 ] . In contrast, sperm aneuploidy 
rates are much lower with an estimated average 
incidence of 1–2 %  [ 20 ] , and the effect of male age 
on sperm aneuploidy rate remains unclear. Some 
studies have failed to  fi nd an effect of male age on 
sperm aneuploidy frequency  [ 14,  22 ] , while others 
have reported a modest increase in aneuploidy 
rates related to age, particularly increased diso-
mies of the sex chromosomes  [ 23– 25 ] . 
 While there is no consensus on the effect of 
male age on sperm aneuploidy rates, the major-
ity of evidence suggests a slight increase in sex 
chromosome disomy rates in older men and a 
general lack of an effect or a weak effect in the 
autosomes  [ 8 ] . 
 3.3.2.3  Increased Mutations 
 The introduction of de novo mutations into the 
genome is the basis for heritable genetic variation, 
and the number of mutations per genome is related 
to the number of replication cycles that a cell 
undergoes, as there is an error rate inherent in rep-
lication machinery. Based on family-based 
sequencing and single sperm sequencing as well 
as evolutionary measures, the de novo mutation 
rate of sperm is estimated to be between 1 and 4 
changes per 100 million bases per generation 
 [ 26,  27 ] , while the mutation rate per cell division 
is almost three orders of magnitude lower than the 
per generation mutation rate  [ 28 ] . The more cycles 
of DNA replication and cell division a cell under-
goes, the greater the chance for mutations to occur 
in that cell. In women, from the primordial germ 
cell stage to ovulation, an oocyte will have under-
gone approximately 24 cell divisions  [ 29 ] . In men 
that number is estimated to be approximately 30 
cell divisions at puberty, with one spermatocyte 
cell division every 16 days, or 23 divisions per 






20 T.G. Jenkins et al.
 Clearly there is a greater opportunity for muta-
tions to arise in sperm than in oocytes, and male 
age is predicted to be a strong contributing factor. 
Lionel Penrose was the  fi rst to propose a relation-
ship between male age and mutations in offspring 
 [ 30 ] . While the mutation load of individual sperm 
as a function of male age has not been directly 
measured, molecular genetics predicts that sperm 
from older men will, on average, harbor more 
mutations than sperm from younger men. This pre-
diction is substantiated by a recent study of genomic 
sequence in parent–offspring trios that estimated 
an increase of approximately two mutations per 
year of paternal age  [ 31 ] . In addition, the increased 
rates of speci fi c autosomal dominant diseases and 
disease-speci fi c mutation analysis also support an 
age effect on sperm mutation frequency  [ 14 ] , as 
will be discussed in detail below. 
 3.3.2.4  Changes in Telomeres 
 While the consequences of advanced paternal age 
on the genetics of sperm are generally negative, 
the age-related changes to sperm telomeres might 
confer some advantage to offspring. Telomeres 
are composed of long tracts of TTAGGG repeats 
located at the ends of each chromosome and serve 
as a buffer to the loss of important genetic material 
due to the inability of DNA replication machinery 
to replicate DNA at the very end of each chromo-
some. In addition, the telomere cap at the end of 
each chromosome distinguishes chromosome 
ends from double strand breaks and thus serves to 
protect against spurious chromosomal fusion  [ 32 ] . 
While in most tissues, telomeres progressively 
shorten with age, ultimately resulting in cell cycle 
arrest or apoptosis, the telomeres in sperm are 
longer in older men  [ 33 ] , and children of older 
fathers have longer leukocyte telomeres than do 
children of younger fathers  [ 34,  35 ] . Telomere 
inheritance may represent an example of a genetic 
advantage of delayed reproduction in men as 
longer leukocyte telomere length is associated 
with decreased risk of atherosclerosis and 
increased lifespan  [ 36 ] . 
 3.3.3  Epigenetic Changes 
 The effect of advanced paternal age on offspring 
has begun to receive much attention. Recent 
studies have linked paternal aging and the preva-
lence of well-known neuropsychiatric disorders 
in offspring  [ 37– 39 ] . Large retrospective studies 
demonstrate the effect of paternal age on various 
birth outcomes, including weight, premature 
deliveries, and various offspring abnormalities 
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 [ 40,  41 ] . Additionally, recent research has begun 
to elucidate associations between aged fathers 
and increased incidence of obesity in offspring. 
These  fi ndings were independent of maternal 
age and other outside factors  [ 42 ] . However, the 
etiology of the increased frequency of various 
disorders in the offspring of aged males remains 
poorly de fi ned, though there are likely 
candidates. 
 In both sexes, aging alters DNA methylation 
marks in most somatic tissues throughout the 
body  [ 43,  44 ] . Because of its prevalence in other 
cell types, aging-associated DNA methylation 
alteration is likely to occur in sperm as well. In 
fact, Oakes et al. have described age-associated 
hypermethylation at speci fi c genomic loci in both 
sperm and liver tissue in male rats  [ 44 ] . Similarly, 
our laboratory has identi fi ed increased global 
DNA methylation associated with age in human 
sperm from fertile donors (unpublished data). In 
further support of this idea is work demonstrating 
that frequently dividing cells have more striking 
methylation changes associated with age than do 
cells which divide less often  [ 45 ] . Additionally, a 
recent study also indicates that, at speci fi c gene 
promoters, there is increased DNA methylation 
in the offspring of older fathers  [ 46 ] . These data 
further suggest the possibility of heritable DNA 
methylation alterations associated with advanced 
paternal age. 
 In addition to DNA methylation alterations 
there are data to suggest alterations in chromatin 
packing that occur with age as well. It has been 
suggested that chromatin remodeling plays a key 
role in cellular senescence, organismal aging, and 
age-associated disease and thus could play a role 
in age-associated sperm alterations that may ulti-
mately affect the offspring  [ 47 ] . In fact, Nijs et al. 
described altered chromatin packing associated 
with age as assessed by the sperm chromatin 
structure assay  [ 48 ] . The subtle nature of the 
effect and, in some cases, the absence of well-
characterized genetic factors, in addition to the 
aging-associated somatic cell methylation altera-
tions, suggest that a major contributing factor to 
the increased prevalence of various diseases 
among the offspring of aged fathers is the sperm 
epigenome. 
 3.4  Reproductive Consequences of 
Age-Related Changes in Sperm 
 3.4.1  Fecundity 
 Among the consequences of delayed paternity, 
and likely the most dramatic alteration that occurs 
with increased paternal age, is that of decreased 
fecundity. Though very different from the univer-
sal and abrupt age-associated cessation of fertility 
seen in females, there is a signi fi cant decline in a 
male’s capacity to produce viable offspring that is 
correlated with age. However, the age at which an 
individual male’s reproductive capacity declines 
and even the frequency of this decline among a 
population of men remains controversial. Despite 
this, there are many studies that demonstrate an 
age effect on male fecundity with study groups, 
including natural conception, arti fi cial insemina-
tion, and in vitro fertilization. 
 In an observational study performed in the 
United Kingdom in 2003, Hassan et al. found that 
men >45 years of age had a  fi vefold increase in 
their time to pregnancy in comparison to individ-
uals <25 years of age  [ 49 ] . Interestingly, when 
compared to males <25, men 45 and older were 
also 12.5 times more likely to have a time to preg-
nancy of greater than 2 years  [ 49 ] . As expected, 
this effect is ampli fi ed when the female member 
of a couple is of advanced reproductive age as 
well (35–39). In these couples, men >40 were 
more than two times more likely to fail to con-
ceive during a 12 month period in comparison to 
men <40  [ 50 ] . Additionally, when taken into 
account unsuccessful pregnancies in the same 
groups men over 40 were three times less likely to 
produce viable offspring than do the younger 
cohort  [ 50 ] . Other studies support these data by 
suggesting an increased frequency of fetal loss 
to those fathered by older men, increased time to 
pregnancy, and decreased probability of concep-
tion  [ 51– 53 ] . However, there are con fl icting data 
which suggest little to no effect of paternal age on 
fertility in natural conception  [ 54 ] . 
 Research has also described effects of paternal 
age on the outcomes of assisted reproductive tech-
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(IUI) cycles analyzed in a French study revealed 
that the pregnancy rate for couples whose male 
partner was less than 30 years of age had a preg-
nancy rate of 12.3 % where couples whose male 
partner was over 30 years of age had a signi fi cantly 
lower pregnancy rate of 9.3 % after adjusting for 
female age  [ 55 ] . Similarly, in 1995, Mathieu et al. 
showed that increasing male age ( ³ 35 years of 
age) was associated with decreased rates of con-
ception  [ 56 ] . However, these data are controver-
sial. Additional studies have failed to  fi nd a 
paternal age effect on IUI pregnancy rates  [ 57 ] . 
Other studies have analyzed the paternal age 
effect on in vitro fertilization (IVF) success with 
a similar controversy. Many studies suggested 
that there is a paternal age effect in achieving 
viable pregnancy outcomes in IVF cycles  [ 58 ] 
and also have suggested that this effect is ampli fi ed 
with partners of advanced maternal age  [ 59 ] . 
In large studies involving the use of donor eggs 
in an IVF cycle showed a signi fi cant effect of 
paternal age on pregnancy outcome  [ 60 ] . However, 
an even more recent study that corrected for age 
of the egg donor found no effect of paternal age 
on pregnancy outcome  [ 61 ] . 
 3.4.2  Disease Risk in Offspring 
 As would be expected, the numerous genetic and 
epigenetic changes that occur to sperm through the 
aging process are associated with elevated risk of 
some diseases in the offspring of older fathers. 
These include several rare, autosomal disorders, 
disorders involving expanded trinucleotide repeats, 
offspring aneuploidy, certain cancers, and several 
neuropsychiatric disorders. These diseases and 
associated risks will be discussed below. While 
risks of these disorders are demonstrably elevated 
in offspring of older fathers, it is important to 
emphasize that the paternal age contribution to 
the increased risk is generally quite low (with the 
exception of the autosomal dominant and triplet 
repeat disorders) and absolute risk for any of 
these disorders remains quite low. 
 3.4.2.1  Autosomal Dominant Disorders 
 Rare autosomal disorders, including Apert syn-
drome and achondroplasia, are among the most 
striking and earliest characterized examples of 
increased disease risk as a consequence of 
advanced paternal age. As early as 1912, it was 
observed that sporadic cases of achondroplasia, 
a dominantly inherited form of dwar fi sm, was 
most often found in the last-born children of a 
family  [ 29 ] . More recently, a number of other 
diseases have been shown to display similar 
paternal age effects. 
 A dozen diseases showing a signi fi cant paternal 
age effect were described in a paper more than 
three decades ago, and several others have been 
described since that time  [ 62 ] . In addition to achon-
droplasia and Apert syndrome, the list of autosomal 
dominant disorders that display a paternal age 
effect includes acrodysostosis,  fi brodysplasia 
ossi fi cans progressive, neuro fi bromatosis, multi-
ple endocrine neoplasia 2A (MEN 2A) and MEN 
2B, and syndromes including Marfan, Treacher-
Collins, Crouzon, Noonan, and Pfeiffer, among 
others  [ 62 ] . 
 Remarkably, many of these conditions, 
including Apert syndrome, achondroplasia, 
Crouzon syndrome, Pfeiffer syndrome, MEN 
2A, and MEN 2B, involve mutations in three 
genes,  FGF3R ,  FGFR2 , and  RET  [ 29,  63 ] . 
Moreover, in almost every case where parental 
origin of the de novo, disease-causing mutation 
in these genes was assessed, the mutation was 
paternally derived  [ 29,  63– 68 ] . In addition, the 
mutated loci linked to many of these disorders 
are among the most frequently mutated nucle-
otides in the entire genome  [ 29 ] . These observa-
tions led to the hypothesis of sel fi sh 
spermatogonial selection, the idea that some 
spermatogonial mutations confer some advan-
tage, leading to clonal expansion of mutant 
sperm over time  [ 63,  69 ] . This mechanism may 
explain, at least in part, the molecular basis for 
the increased incidence of these disorders with 
advanced paternal age. 
 While it is well established that increasing 
paternal age does increase the risk for numerous 
autosomal dominant disorders, it is important to 
note that the absolute risk for these diseases 
remains quite low. Additional research is required 
to fully characterize the mechanisms involved in 
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 3.4.2.2  Trinucleotide Repeat Disorders 
 In addition to the association between point muta-
tions in the male germline and male age, there is 
also evidence to suggest that other genomic 
changes, namely changes in trinucleotide repeat 
length, are also more frequent in the germline of 
older men. The cause of Huntington’s disease has 
been traced to an expanded block of CAG tandem 
repeats within the Huntingtin ( HTT ) gene  [ 70 ] . 
Longer triplet repeats in  HTT result in altered 
protein function and Huntington’s symptoms. It 
was demonstrated that repeat expansion is almost 
entirely driven through the male germline  [ 71 ] , 
and the extent of repeat expansion is signi fi cantly 
associated with paternal age  [ 72 ] . 
 Myotonic dystrophy (DM) is another disease 
associated with trinucleotide repeat expansion. 
Like Huntington’s disease, expanded CTG 
repeats are more frequently transmitted from the 
father  [ 73 ] , and paternal age appears to be a risk 
factor for transmission of the disease  [ 74 ] . One 
large study of 3,419 cases of Down syndrome did 
 fi nd a signi fi cant paternal age effect after adjust-
ing for maternal age when mothers were older 
than 35, and the paternal age effect was most 
signi fi cant when maternal age was over 40  [ 75 ] . 
 3.4.2.3  Offspring Aneuploidy 
 The majority of aneuploidies are embryonic lethal, 
however trisomies 13, 18, and 21 along with sex 
chromosome aneuploidies (XXY, XYY, XXX, 
XO, etc.) are compatible with life. The great 
majority of somatic aneuploidies are maternally 
derived. For example in a cohort of 352 cases of 
Down syndrome, approximately 91 % were of 
maternal origin, and a maternal contribution to 
other cases of trisomy involving chromosomes 13, 
14, 15, and 22 were similar, ranging from 83 to 
89 %  [ 76 ] . Interestingly, the story is different for 
sex chromosome aneuploidies, with a little more 
than half of cases being paternally derived  [ 20 ] . 
 Given the relatively minor effect of paternal 
age on sperm aneuploidy rates, it is not surpris-
ing that epidemiologic data for the paternal con-
tribution to trisomic offspring generally do not 
support a paternal age effect  [ 8,  77,  78 ] . A recent 
study based on 22 EUROCAT congenital anomaly 
registers identi fi ed a marginally signi fi cant asso-
ciation between paternal age and Klinefelter 
syndrome  [ 79 ] . Several studies have evaluated 
the relationship between paternal age and inci-
dence of Down syndrome, and in general have 
reported a weak paternal age effect  [ 80 ] or no 
effect at all  [ 81 ] . Based on available data, clearly 
the paternal age effect on offspring aneuploidy is 
relatively small and is eclipsed by the signi fi cant 
maternal age effect. 
 3.4.2.4  Cancer 
 Based on the current literature, it appears that 
paternal age may have an effect on incidence of 
various types of cancers in offspring. These data 
are intriguing but remain quite controversial. 
One of the most heavily studied classes of dis-
ease in these studies is hematological cancers. 
A recent epidemiological study has described a 
decreased risk of acute myeloid leukemia in 
 fi rstborn children, indirectly suggesting that 
maternal and paternal age may play a role in the 
frequency of cancer incidence in the offspring. 
The same study was able to directly detect an 
increased risk of being diagnosed with any form 
of childhood leukemia in children sired by fathers 
of between 35 and 45 years of age when com-
pared to fathers <25 years of age  [ 82 ] . In agree-
ment with these data is research by Murray et al. 
which suggests that children born to fathers >35 
years of age are 50 % more likely (relative 
risk = 1.5) to receive a diagnosis of a childhood 
leukemia  [ 83 ] . However, a Swedish epidemio-
logical study published in 1999 detected no 
signi fi cant impact of paternal age on hematologic 
cancers  [ 84 ] . 
 The impact of paternal age on offspring cancer 
incidence is not limited to hematologic metasta-
ses. There also appears to be an increased risk of 
developing childhood central nervous system 
tumors in the offspring of older fathers. One ret-
rospective study showed that children born to a 
father >30 years of age were at a 25 % increased 
risk of developing a childhood brain tumor com-
pared to children of fathers <25 years  [ 84 ] . 
Similarly, Yip et al. demonstrated that the off-
spring of fathers >40 had an increased relative 
risk (approximately 1.7) of developing a central 
nervous system cancer  [ 85 ] . 
 Advanced paternal age also appears to affect 
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The incidence of breast cancer has been shown to 
increase in the daughters of fathers who are >40 
compared to fathers <30  [ 86 ] . Similarly, prostate 
cancer risk increases by approximately 70 % in 
the offspring of fathers >38 years of age compared 
to the children of fathers <27 years of age  [ 87 ] . 
 The mechanism behind this effect is likely 
multifactorial and may additionally vary by race. 
However, there are some candidates that likely 
play at least some role in the etiology of increased 
incidence of multiple cancers seen in the off-
spring of aged fathers. Environmental exposures 
that accumulate throughout the life of a male are 
one of the most likely effectors, as this may affect 
subtle DNA mutations and epigenetic alterations 
that are capable of being inherited. In fact, as 
mentioned earlier, there are some data that suggest 
that the offspring of older fathers have increased 
levels of DNA methylation at speci fi c loci  [ 46 ] . 
If any of these alterations (gene mutations or epi-
genetic modi fi cations) occur at tumor suppressor 
genes or other important genes in the etiology of 
various cancers, the result would be increased can-
cer incidence as is seen in the current literature. 
Though this correlation is intriguing, it should be 
noted that much work is still required to further 
de fi ne the effects of paternal aging on the inci-
dence of cancer in offspring. 
 3.4.2.5  Neuropsychiatric Disorders 
 In recent years, with the application of genomic 
tools, the genetic complexity of neuropsychiatric 
disorders is becoming increasingly apparent. 
However, it has long been suggested that advanced 
paternal age is a risk factor for schizophrenia 
 [ 88 ] , and more recently, advanced paternal age 
has been implicated in risk for autism, bipolar 
disorder, behavioral disorders, and reduced cog-
nitive ability. 
 The paternal age effects on schizophrenia risk 
have been widely studied  [ 89– 91 ] . A recent 
meta-analysis representing 24 qualifying studies 
con fi rmed advanced paternal age to be a signi fi cant 
risk factor for schizophrenia  [ 89 ] . In this study, 
the authors reported a slight but signi fi cant 
increase in the risk of developing schizophrenia in 
offspring from fathers >30 years of age, with rela-
tive risk (RR) increasing in older fathers. At the 
extreme, a combined RR for schizophrenia in the 
offspring of fathers >50 years of age compared 
with fathers age 25–29 was 1.66  [ 89 ] . Interestingly, 
there also appears to be a slight but signi fi cant risk 
of schizophrenia in offspring of fathers < 25 years 
(RR = 1.08) only in male offspring  [ 89 ] . 
 Associations between paternal age and risk of 
autism spectrum disorders (ASD) have also been 
thoroughly investigated, with two meta-analyses 
con fi rming a signi fi cant association  [ 92,  93 ] . In 
the most recent population-based study and meta-
analysis, it was estimated that fathers >50 years 
of age had a 2.2-fold increased risk of autism in 
offspring compared with men aged 29 years or 
less  [ 93 ] . 
 The data regarding the association between 
paternal age and other neuropsychiatric and 
behavioral disorders are less clear, but there does 
seem to be an increase in bipolar disorder  [ 94, 
 95 ] and behavioral issues  [ 96,  97 ] in children of 
older fathers. In addition, some studies indicate 
that children of older fathers display slightly 
reduced IQ compared with children of younger 
fathers  [ 98,  99 ] , although the differences are 
small, and con fl icting reports exist  [ 100 ] . 
 While evidence clearly suggests that paternal 
age does have some impact on neurological devel-
opment and the incidence of neuropsychiatric dis-
orders, the mechanisms for neurodevelopmental 
changes have not been elucidated. It has been 
suggested that increased risk may be related to 
increased mutations  [ 101 ] , changes in gene dos-
age as a result of copy number changes in the 
genome  [ 102 ] , or epigenetic changes associated 
with age  [ 103 ] . It is also likely that behavioral 
factors in the fathers that result in delayed mar-
riage also contribute  [ 88 ] , as these factors are 
very dif fi cult to quantify and correct for in epide-
miological studies. 
 3.4.3  Consequences in Context 
 From the available data, it is clear that advanced 
paternal age affects sperm quality, fecundity, and 
offspring health. However, this topic is only begin-
ning to be thoroughly explored partially due to the 
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appears to have driven increased media attention 
toward to the study of advanced paternal age and 
offspring health. This has placed many physicians 
in the dif fi cult position of consulting concerned 
patients regarding their capacity to produce healthy 
offspring with only scant amounts of data from a 
 fi eld of study in its relative infancy. This discus-
sion is fascinating and extremely complex as a 
result of the socioeconomic, emotional, and gen-
eral health issues involved. Physicians should be 
prepared to address many questions from their 
patients, but should speci fi cally be able to address 
two main concerns in this discussion. The  fi rst are 
patients who request to preemptively store sperm 
at relatively young ages as an alternative to natural 
conception at an advanced age. The second are 
male patients who seek advice on the “risks” of 
having children at advanced age. In either case, the 
patients must be well informed and comfortable in 
making their decisions. 
 Are cryopreserved sperm from a young healthy 
individual more capable of producing healthy 
offspring than fresh sperm from the same indi-
vidual collected at an advanced age? This central 
question in the paternal aging debate is not easily 
addressed. In fact, the most accurate answer 
would be that we simply do not know. It is clear 
that advanced paternal age has been associated 
with increased incidence of many disease states 
in the offspring as has been previously outlined. 
It is also known that there is a slightly increased 
risk of birth defects in children conceived through 
in vitro fertilization (the advanced reproductive 
technology that would most likely be used in 
these cases). Additionally, though still contro-
versial, it has been demonstrated that the cryo-
preservation of sperm, even in the presence of 
cryomedium, can result in DNA damage thus 
compounding the problem of using stored samples 
as an alternative to natural conception at an 
advanced age  [ 104 ] . Despite this, because of the 
low risk in cryopreservation of male gametes, if a 
patient desires to store sperm at a young age with 
the intent of future use, it would not be unreason-
able to support this decision if the patient has 
been well educated on the available data. 
 Patients of advanced age who are considering 
having children but have not previously stored 
sperm may also seek medical advice on whether 
or not they should attempt parenthood based on 
the recent data that demonstrates increased rela-
tive risk to the offspring. Would they be placing 
their offspring at a signi fi cant risk/disadvantage? 
In response to this question it is important to 
understand that while the data do suggest a rela-
tive increase in the risk of offspring of aged 
fathers developing many disorders and diseases 
including, but not limited to schizophrenia, 
autism and even cancer, the absolute risk of these 
are still very low. For example, the risk of devel-
oping childhood leukemia is approximately 1 in 
25,000 in the general public, and in the offspring 
of older fathers that risk climbs to 1 in 17,000, 
approximately a 50 % increase  [ 83 ] . Though the 
relative risk in this case is statistically signi fi cant, 
the absolute risk to the offspring of an aged father 
actually developing leukemia remains very low. 
It will be important for physicians to additionally 
encourage patients to consider their familial rela-
tionships and the emotional bene fi ts of having 
children and weigh these with the subtle increases 
in risk of having children at an older age. In con-
sulting male patients of an advanced age, the data 
do not support the recommendation of halting 
attempts at conception because of the risks to the 
offspring as it does in advanced maternal age. 
Despite this it is important to consider these risks 
and understand that the cumulative data on the 
disorders that have relatively increased prevalence in 
the offspring of older fathers may dissuade some 
from having children at an older age. 
 3.5  Conclusions 
 In recent years, we have learned a great deal 
regarding the effect of aging on male fertility. 
Advanced paternal age is negatively associated 
with many semen parameters, and these negative 
effects likely drive the general decrease in fertility 
and fecundity seen in males of advanced age. 
Though not an abrupt and complete loss of fertil-
ity as seen in advanced maternal aging, there is a 
gradual decrease in gamete quality associated 
with aging in males. This decrease in quality 
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and epigenetic alterations that appear to be capable 
of causing abnormalities in the offspring. Though 
we currently have evidence to support the pater-
nal age associated increase in offspring disease 
susceptibility, the absolute risk remains quite 
low. Despite this, couples with an aged male 
partner should consider these risks and discuss 
them with their health care provider to determine 
their best course of action in their desire to con-
ceive a child. 
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 Paternal aging and associated
intraindividual alterations of global
sperm 5-methylcytosine and
5-hydroxymethylcytosine levels
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Objective: To evaluate the relative intraindividual changes in sperm 5-methylcytosine (5-mC) and 5-hydroxymethylcytosine (5-hmC)
levels associated with age and to compare the levels of 5-hmC in mature human sperm to blood DNA.
Design: Prospective research study.
Setting: University-based andrology and in vitro fertilization (IVF) laboratory.
Patient(s): Fifteen known fertile sperm donors, 22 other known fertile controls, and 41 male blood donors from a general population
tissue bank.
Intervention(s): None.
Main Outcome Measure(s): Measurements of global 5-mC and 5-hmC levels via an enzyme-linked immunosorbent assay (ELISA)-
based assay.
Result(s): Global sperm 5-mC levels exhibit a statistically signiﬁcant increase with age, and a similar trend was seen in 5-hmC levels.
On average, in the age ranges we analyzed, 5-mC increased by 1.76% per year, and 5-hmC, though more variable, increased by
approximately 5% per year. Additionally, we found that 5-hmC levels in sperm are 32.59% of that found in blood DNA.
Conclusion(s): Global sperm DNAmethylation patterns are stable over short periods of time but increase with age, which raises impor-
tant questions regarding the risks of advanced paternal age. Additionally, as we would predict for a transcriptionally quiescent cell type,
5-hmC levels are statistically signiﬁcantly lower in human sperm than in blood DNA. (Fertil
Steril! 2013;100:945–51. "2013 by American Society for Reproductive Medicine.)
Key Words: Advanced paternal age, global DNA methylation, 5-hydroxymethylcytosine,
5-methylcytosine, sperm DNA methylation
Discuss: You can discuss this article with its authors and with other ASRM members at http://
fertstertforum.com/carrelldt-advanced-paternal-age-dna-methylation/
Use your smartphone
to scan this QR code
and connect to the
discussion forum for
this article now.*
* Download a free QR code scanner by searching for “QR
scanner” in your smartphone’s app store or app marketplace.
A ging is known to severely affectfemale fertility, includingelevating the risk of sponta-
neous abortion, chromosomal defects
in the offspring, preterm delivery, and
intrauterine growth restriction (1). In
contrast, the effect of advanced paternal
age on fertility, pregnancyoutcome, and
offspring health has received far less
attention. However, recent studies link-
ing older fathers to an increased preva-
lence of several neuropsychiatric
disorders in the offspring has increased
interest on the effect of advanced
paternal age on offspring health. Specif-
ically, various reports have linked
increased paternal age at conception
with bipolar disorder, schizophrenia,
and autism in humans as well as
decreased social and exploratory
behavior in animal models (2–5).
Additionally, studies have shown an
association between advanced paternal
age and increased DNA damage and
decreased chromatin integrity in
addition to adverse birth outcomes,
including alterations in weight,
premature delivery, and various other
offspring abnormalities (6–9).
The etiology of the increased fre-
quency of these various disorders in
the offspring of aged males remains
poorly deﬁned, though epigenetic
mechanisms are an obvious possibility.
It has been demonstrated that DNA
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 methyltransferase 3a (DNMT3a) and 3b (DNMT3b) expression
increases with the age of the tissues investigated (10). Addi-
tionally, it is known that DNA methylation is altered in
many somatic cell types with age, but similar changes in
the sperm remain uncharacterized (11, 12). Despite this, the
age-related DNA methylation modiﬁcations that occur in
virtually every other tissue in the body suggest that similar
patterns exist in sperm. In further support of this idea is
work demonstrating that frequently dividing cells have
more striking methylation changes associated with age than
do cells that divide less often (13). Thus, alterations in sperm
DNAmethylation represent an undeﬁned but highly plausible
mechanism contributing to the increased incidence of neuro-
psychiatric disorders seen in the offspring of older fathers.
Our understanding of the paternal epigenetic landscape
has increased dramatically in the recent past. Among the
important epigenetic marks in sperm is DNA methylation at
cytosine residues (5-mC). These marks are typically associated
with gene silencing by inhibiting access of transcription-
related binding proteins to the DNA. Recently, there has
been increased interest in the role ofDNAdemethylation inter-
mediates such as 5-hydroxymethylcytosine (5-hmC), which is
formed by the 10-11 translocase (TET) family of enzymes.
These marks are thought to play a regulatory role in gene
expression and/or poising. The current literature describes
unique epigenetic marks in sperm that are capable of facili-
tating proper function in the mature gamete as well as marks
that are uniquely capable of poising speciﬁc genes in the early
embryo for activation (14, 15). These data establish the
importance of the paternal germline for embryogenesis in a
way that was never previously understood.
It is clear from the available evidence that the inheritance
of DNAmethylation alterations is a plausible candidate for the
etiology of many heritable disorders previously considered
idiopathic in nature. Additionally, aberrations in the sperm
methylomemay contribute to the elevated risk of certain disor-
ders associated with advanced paternal age. We describe the
relative changes in globalDNAmethylation that occur through
the process of aging by comparing semen samples collected by
spermdonorsmanyyears apart. This study involved three basic
aspects. First, we sought to determine the effect of aging on
sperm 5-mC and 5-hmC levels. Second, we analyzed the intra-
individual variability of 5-mC and 5-hmC levels in samples
collected within 14 days of each other. Finally, we evaluated
the difference in 5-hmC levels in sperm and blood DNA.
MATERIALS AND METHODS
Study Participants
Our laboratory has a research tissue bank that includes sperm
and blood samples from previous sperm donors. Fifteen
semen donors of known fertility who had previously banked
samples at our laboratory were asked to return and collect a
sample in 2008 under a protocol approved by the institutional
review board. The time between the sample collections varied
between 9 and 21 years. The basic semen analysis data for the
two collections are available in Supplemental Table 1 (avail-
able online). The age at early collection for the donors in our
sample set was between 27 and 56 years (Fig. 1; Table 1). To
determine the intraindividual variability of sperm DNA
methylation levels, 17 sperm donors collected three samples
during a period of less than 14 days. These samples were
used to test the consistency of sperm DNA methylation over
a very short period of time.
To compare the levels of 5-hmC in sperm and blood DNA,
we analyzed 52 sperm samples and 41 blood samples from our
general population tissue bank. These donors are from a
nonselected pool of men (Table 1).
Sample Collection and DNA Extraction
The men provided both semen and blood samples. The donors
were required to strictly follow the University of Utah Androl-
ogy Laboratory collection instructions, which include absti-
nence time of between 2 and 5 days. After collection, the
samples were frozen with test yolk buffer (TYB; Irvine Scien-
tiﬁc) and were stored in liquid nitrogen before DNA isolation.
No sperm selection method was employed as it was our aim to
observe changes to all sperm in the ejaculate.
The samples were thawed and DNA extracted simulta-
neously to decrease batch effects. Sperm DNA was extracted
using a sperm-speciﬁc extraction protocol used routinely in
our laboratory. Before DNA extraction, we employed a
FIGURE 1
Illustration of the ages at which donors collected their samples. Nine
of the 15 donors collected three samples, and the remaining six
donors only collected two samples.
Jenkins. Sperm DNA methylation and aging. Fertil Steril 2013.
TABLE 1





index (±SEM) Age (±SEM)
Young 15 27.05 (!0.93) 39.33 (!2.02)
Aged 15 28.32 (!1.37) 53.27 (!1.92)
General population
Blood samples 41 27.16 (!0.88) 37.64 (!1.65)
Sperm samples 52 26.44 (!0.46) 38.20 (!1.18)
Jenkins. Sperm DNA methylation and aging. Fertil Steril 2013.
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 somatic cell lysis protocol that includes incubation in somatic
cell lysis buffer (0.1% SDS, 0.5% Triton X-100 in DEPC H2O)
for 20minutes on ice to eliminate white blood cell contamina-
tion. After somatic cell lysis, we performed a visual inspection
of each sample to ensure the absence of all potentially
contaminating cells before proceeding (16). Sperm DNA was
then extracted using enzymatic and detergent-based lysis fol-
lowed by treatment with RNase and ﬁnally by DNA precipita-
tion using isopropanol and salt, with subsequent DNA
cleanup using ethanol.
Blood samples were obtained by venipuncture, and they
were immediately frozen and stored at !80"C until DNA
extraction. Blood DNA was extracted using Puregene DNA
puriﬁcation kit (Gentra Systems) according to the manufac-
turer's recommendations.
Global 5-mC and 5-hmC Measurement
We usedMethylFlash Colorimetric Methylated DNA Quantiﬁ-
cation Kit and HydroxyMethylated DNA Quantiﬁcation Kit
(Epigentek) for the quantiﬁcation of 5-mC and 5-hmC,
respectively. This enzyme-linked immunosorbent assay
(ELISA) kit has been established as a quick, effective, and
inexpensive method for the relative quantiﬁcation of global
5-mC and 5-hmC levels in many tissues types from various
species (17–20). The assays were performed according to the
manufacturer's recommendations. Brieﬂy, 100 or 200 ng of
genomic DNA was used for 5-mC or 5-hmC quantiﬁcation,
respectively. It is important to note that the paired samples
were analyzed simultaneously on the same plate in neigh-
boring positions to decrease the possibility of experimental
variance, and each sample was run in duplicate. Additionally
we performed two technical replicates for 5-mC and 5-hmC
assays to evaluate assay variability.
After incubation with the input DNA, the wells were
washed, and a capture antibodywas applied to eachwell, after
which the wells were again washed and detection antibody
applied. Use of enhancer solution and development solution
created a color change proportional to the quantity of 5-mC
or 5-hmC, and the samples were read on an automated plate
reader at 450 nm absorbance. The use of a standard curve
enabled the quantiﬁcation of 5-mC or 5-hmC based on absor-
bance measurements.
Microarray Analysis
Paired samples from two representative donors were selected
to conﬁrm the global sperm methylation results that we
observed. Extracted sperm DNA was bisulﬁte converted
with EZ-96 DNA Methylation-Gold kit (Zymo Research) ac-
cording to the manufacturer's recommendations. Converted
DNA was then delivered to the University of Utah Genomics
Core Facility and hybridized to Inﬁnium Human Methylation
450 Bead Chip micro-array (Illumina) and analyzed according
to Illumina protocols. Once the DNA were scanned and
analyzed for quantities of methylation or lack of methylation
at each CpG, we generated b value by applying the average
methylated and unmethylated intensities at each CpG using
the calculation: b value ¼ Methylated/(Methylated þ Unme-
thylated). This b value ranges from 0 to 1 and indicates the
relative levels of methylation at each CpG, with highly meth-
ylated sites scoring close to 1 and unmethylated sites scoring
close to 0.
Statistical Analysis
The relationship between age and 5-mC or 5-hmC quantiﬁca-
tion was measured in two ways. First, linear regression anal-
ysis was used to determine the relationship between age at
time of collection and the levels of 5-mC and 5-hmC. Each
of the 15 donors is represented twice in this data set (once
for each collection). Second, to further investigate the varia-
tion that occurs within each individual with age, we normal-
ized the 5-mC and 5-hmC levels for three collections from
each individual. We accomplished this by determining the
average 5-mC and 5-hmC levels that were found in each in-
dividual across three collections and then divided the 5-mC
and 5-hmC levels at each collection by the average quantity
for that individual. In this way, we were able to generate a
normalized data point for each collection from each individ-
ual to assess the relative changes between collections for that
individual.
Normalized data were subjected to Levene's homogeneity
of variance analysis to determine whether DNA methylation
in an individual over many years was more variable than
over only a short period of time (i.e., 2 weeks). Finally, to
determine the statistical signiﬁcance of the difference in
blood and sperm 5-hmC levels, we used a Student's t test.
All statistical analyses were performed using the STATA 11
software package, and P< .05 was considered statistically
signiﬁcant.
RESULTS
Aging and Sperm 5-mC and 5-hmC Levels
To evaluate the global DNA methylation alterations that
occur with age, we analyzed the earliest available collection
and the 2008 collection for each of the 15 donors (collection
1 and 2 in Fig. 1). The ages represented in this analysis ranged
from 27 to 70 years. In our analysis, we found that there was a
statistically signiﬁcant positive correlation between paternal
age and sperm global 5-mC levels (r ¼ 0.475; P¼ .008)
(Fig. 2A). A similar pattern was found with 5-hmC (r ¼
0.38; P¼ .038) (Fig. 2B). On average, 5-mC increased by
1.76% per year in our sample set; 5-hmC, though more vari-
able, increased by approximately 5% per year in our sample
set. It is important to note that, based on the general appear-
ance of the linear regression plot, it is possible that within the
5-mC data set a multiphasic correlation exists to age such that
5-mC is relatively stable up to approximately 55 to 60 years of
age, at which point 5-mC dramatically increases. However,
we are unable to statistically conﬁrm this relationship due
to our low sample size in this age category.
To conﬁrm these results, we additionally subjected paired
samples from two representative donors to array analysis. The
results demonstrated a modest increase in methylation with
age in each sample at the%450,000 CpGs probed, the majority
of which are located in well-deﬁned CpG islands and other
VOL. 100 NO. 4 / OCTOBER 2013 947
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 regulatory regions. It is interesting that at the !50,000 CpGs
probed in regions outside of CpG islands, the CpG shores, CpG
shelves, or other deﬁned regulatory features, there was a
1.02% increase in average b value over a period of 15 years in
the ﬁrst donor and a 1.07% increase in average b value over a
period of 10 years in the second donor (Supplemental Fig. 1).
In both donors, this age-associated hypermethylation in
regionsoutside ofwell-deﬁned regulatory featureswas strongly
statistically signiﬁcant based on a paired t test (P< .0001).
Intraindividual Variability
To test the intraindividual variability associated with aging,
samples from each donor were normalized to demonstrate
the relative variability between samples, as described earlier.
Two tests were performed: the ﬁrst analyzed the variability
that arose between the young and aged samples form the 15
donors over a period of 9 to 21 years, and the second analyzed
intraindividual variability between ejaculates collected
within 14 days of each other.
We found that the 5-mC levels in samples collected
within a short interval had a relatively low degree of intrain-
dividual variance with a coefﬁcient of variance (CV) of
12.42% (standard error of the mean [SEM]" 0.0181). Samples
collected between 9 and 21 years apart had a CV of 32.23%
(SEM " 0.0551). We subjected these two sample sets to a ho-
mogeneity of variance statistical analysis (Levene's test) and
determined that samples collected years apart showed a
statistically signiﬁcantly increased degree of variance
(P< .001). The same analysis was performed for 5-hmC levels,
and we found a high degree of intraindividual variance in
samples collected years apart (CV ¼ 48.69%; SEM "
0.0904). It is interesting that in samples collected within a
short interval we found similar variability (CV ¼ 43.36%;
SEM " 0.0834). These results were not statistically signiﬁ-
cantly different (P¼ .587). Additionally, we ran two sets of
FIGURE 2
(A) Global sperm 5-methylcytosine (5-mC) is positively correlated with age based on linear regression analysis (R ¼ 0.475; P¼.008). (B) Similarly, it
was found that 5-hydroxymethylcytosine (5-hmC) levels in sperm are positively correlated with age (R ¼ 0.38; P¼.038).
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 technical replicates for both the 5-mC assay and the 5-hmC
assay. The CV for the 5-mC assay for both replicates was
6.8% and 6.3%. For the 5-hmC assay, this variability was
slightly higher with a CV of 12.9% and 13.2%.
Sperm Versus Blood DNA 5-hmC Content
While measuring the relative levels of 5-hmC in sperm sam-
ples we noticed that nearly all samples were at approximately
the lowest threshold of the assay. In fact, in multiple samples
5-hmC was undetectable. With this in mind, we sought to
investigate sperm 5-hmC levels relative to blood levels to
conﬁrm our results and provide a baseline measure from
another tissue type known to have very low 5-hmC levels
(21). Based on a t test analysis of 41 blood samples and 52
sperm samples, we found a statistically signiﬁcantly
decreased level of 5-hmC in sperm DNA compared with blood
(P< .0001) (Fig. 3). We found the difference to be quite strik-
ing, with sperm DNA having approximately only 32.59% the
amount of global 5-hmC of blood DNA.
DISCUSSION
Our data indicate a statistically signiﬁcant increase in global
sperm 5-mC levels associated with age in a known fertile pop-
ulation. This difference was coupled with increased intraindi-
vidual variance in global sperm 5-mC associated with age
when compared with the variability seen between collections
only a few days apart. These data demonstrate that spermDNA
methylation levels undergo statistically signiﬁcant changes
with age, although the impact of these alterations is unknown.
Our goal was to perform a descriptive study with a unique
sample set to analyze the epigenetic alterations in sperm that
are associated with age, as these are likely candidates to
contribute to the etiology of some cases of paternal age
related disorders. Because this is a descriptive study, it will
be important in the future to directly study the impact these
alterations have on offspring in animal models and largely
expanded human studies. In light of the modest number of
donors that we were able to analyze in this study, as a result
of the difﬁcult nature of obtaining these paired samples from
collections greater than 10 years apart, we did not investigate
any adverse outcomes from any of the donor offspring as the
sample size was too small to detect any change in frequency
of offspring abnormalities. Despite this, our ﬁndings, specif-
ically DNAmethylation alterations with age, are in agreement
with many other studies that have previously reported alter-
ations to DNA methylation marks and DNMT expression in
various somatic tissues (10–12).
In light of the degree of global alterations to the sperm
methylome identiﬁed in this study, and as our preliminary
array data suggest, it is likely that a large portion of these
changes have occurred outside of CpG islands or other regu-
latory regions. Thus, these changes may be occurring at
repeatable elements or other noncoding, nonregulatory re-
gions, which account for the majority of methylation in the
genome. Based on our current understanding of the sperm ep-
igenome, DNA methylation alterations in these outlying re-
gions may be limited in their ability to produce biologically
relevant changes. However, these large-scale, global alter-
ations to the epigenetic program may also reﬂect more subtle
and important changes, such as alterations to gene promoter
methylation. Additionally, it should be noted that the anti-
body used to detect 5-mC is incapable of discriminating be-
tween CpG methylation and non-CpG methylation, which
could also contribute to the changes in global methylation
status reported herein.
In addition, recent literature has indicated that there is an
association between human sperm global hypermethylation
and apoptosis, suggesting that our ﬁndings may be a result
of the increased incidence of apoptotic cells in older males'
FIGURE 3
Forty-one blood samples from our general population tissue bank were analyzed for 5-hydroxymethylcytosine (5-hmC) levels. Fifty-two sperm
samples from donors and known fertile controls within our tissue bank were also assessed for 5-hmC levels. We determined that sperm 5-hmC
levels are statistically signiﬁcantly lower than the levels found in blood (P<.0001).
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 sperm population (22). Though there are many potential ex-
planations for the alterations we have seen with age, it is
impossible to determine the biologic relevance of these
changes without further investigation with higher resolution
technologies, such as bisulﬁte sequencing or expanded mi-
croarray analysis. Despite this, we have described an
intriguing alteration to the sperm epigenome associated
with age in a unique sample set. Although they are not
descriptive of the precise CpG loci that have been altered or
independently explanatory of any mechanism for these
changes, these data warrant further investigation as they pro-
vide us with the ﬁrst available characterization of sperm DNA
methylation alterations associated with age.
In addition to the changes in 5-mC content in sperm cells,
we found alterations to the levels of 5-hmC with age. Specif-
ically, we found that global sperm 5-hmC levels increase with
age. It should be noted that while we did observe a statistically
signiﬁcant increase in 5-hmC associated with aging and a
high degree of variability (CV¼ 48.69%) in samples collected
between 9 and 21 years apart, the samples collected only a few
days apart displayed a statistically similar level of variability
(CV ¼ 43.36%). With this in mind, it will be important to
further investigate these observed alterations with higher res-
olution technologies in the future.
The low levels of 5-hmC in sperm and the lack of litera-
ture describing this epigenetic modiﬁcation in the male
gamete led us to investigate this unique ﬁnding further. Pre-
vious studies have demonstrated that human blood has
among the lowest levels of 5-hmC among tissues analyzed,
thus we selected blood as a reference point to determine the
relative differences in global 5-hmC levels (21). Though the
idea is still controversial, it has been hypothesized that gene
body 5-hmC enrichment is associated with transcription acti-
vation (21, 23). If correct, this proposed mechanism would
suggest that 5-hmC levels should be very low in the transcrip-
tionally quiescent mature sperm. In agreement with this hy-
pothesis, and despite the high degree of variability seen
between sperm samples, we found a strikingly statistically
signiﬁcant decrease (approximately threefold) in 5-hmC
levels in sperm when compared with blood DNA. These ﬁnd-
ings also comport with the relatively high levels of global 5-
hmC that have been reported in whole testis tissue (21), where
somatic cells and spermatogonial stem cells are transcription-
ally active.
Our ﬁndings regarding 5-mC alterations in human
sperm associated with age represent the ﬁrst study of its
kind. Similarly, from our investigation, these data represent
the ﬁrst analysis of global 5-hmC levels in human sperm.
These unique data provide an excellent foundation upon
which future studies can expand these ﬁndings with the
use of high-resolution technologies to enable us to observe
changes at the single CpG level across multiple loci. This
future work will allow us to understand not only the loci
at which alterations occur but to predict their biologic rele-
vance to the mature sperm, the embryo, and possibly the
offspring. Additionally, our data demonstrating low levels
of 5-hmC in the mature sperm provide evidence that sup-
ports the previously proposed hypothesis that 5-hmC enrich-
ment in gene bodies is associated with transcriptional
activity. Taken together, these data describe relative changes
to sperm DNA methylation associated with age as well as the
differences in 5-hmC levels in sperm versus leukocytes.
Future studies should further investigate these changes to
elucidate the possible effects these alterations may have
on offspring phenotype.
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 SUPPLEMENTAL FIGURE 1
Microarray analysis of paired samples from two representative donors from our study population. Average b values for all 450,000 CpGs probed on
the array (A) and for the!50,000 CpGs that are located outside of deﬁned regulatory regions (B) are represented here. In both donors, the increase
in methylation at CpGs outside of deﬁned regulatory regions was strongly statistically signiﬁcant based on a paired t test.
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951.e1 VOL. 100 NO. 4 / OCTOBER 2013
ORIGINAL ARTICLE: ANDROLOGY
32
 SUPPLEMENTAL TABLE 1
Donor semen analysis data.
Parameter Young (±SEM) Aged (±SEM) P value
Volume 3.78 (!0.46) 2.85 (!0.45) .0142
Million/mL 125.4 (!9.16) 145.56 (!15.57) >.05
Total count 434.32 (!53.67) 424.67 (!88.69) >.05
Total motile 63.38 (!1.64) 61.25 (!4.34) >.05
Percentage live 69.08 (!1.47) 61.0 (!3.93) >.05
Jenkins. Sperm DNA methylation and aging. Fertil Steril 2013.








AGE-ASSOCIATED SPERM DNA METHYLATION ALTERATIONS: 




The effects of advanced paternal age have only recently become of interest to the 
scientific community as a whole. This interest has likely arisen as a result of recent 
studies that suggest an association with increased incidence of diseases and abnormalities 
in the offspring of older fathers. Specifically, offspring sired by aged fathers have been 
shown to have an increased incidence of neuropsychiatric disorders (autism, bipolar 
disorder, schizophrenia, etc.) 1-3, trinucleotide repeat associated diseases (myotonic 
dystrophy, spinocerebellar atixia, Huntington’s disease, etc.) 4-7, as well as some forms of 
cancer 8-11. Though these are intriguing data, we know very little about the etiology of the 
increased frequency of diseases in the offspring of older fathers. Among the most likely 
contributing factors to this phenomenon are epigenetic alterations in the sperm that can 
be passed on to the offspring. 
These studies are in striking contrast to the previously held dogma that the mature 
sperm are capable only of the safe delivery of the paternal DNA and little more. 
Intriguingly, with increased investigation has come mounting evidence that the sperm 
epigenome is not only well suited to facilitate mature gamete function but is also 
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competent to contribute to events in embryonic development. It has been established that 
even through the dramatic nuclear protein remodeling that occurs in the developing 
sperm, involving the replacement of histone proteins with protamines, some nucleosomes 
are retained 12. Importantly, histones are retained at important genomic loci for 
development, suggesting that the sperm epigenome is well suited to poise the paternal 
DNA for embryogenesis. Similarly, DNA methylation marks in the sperm have been 
identified that likely contribute to embryonic development as well 13. These data strongly 
support the hypothesis that the sperm epigenome is not only well suited to facilitate 
mature sperm function, but that it also contributes to events beyond fertilization.  
The contribution of the sperm appears to reach beyond embryogenesis as well. 
The remarkable claim that sperm, independent of gene mutation, may be capable of 
affecting phenotype in the offspring was initially proposed as a result of large 
retrospective epidemiological studies observing changes in the frequency of diseases in 
the offspring of fathers who were exposed to famine conditions in the early 19th century 
14,15. Recently, many studies utilizing animal models have discovered similar patterns that 
comport with the epidemiological data. Specifically, in male animals fed a low protein 
diet, offspring display altered cholesterol metabolism in hepatic tissue 16. However, the 
etiology of this phenomenon is poorly understood. Despite this, there are multiple likely 
candidates that may drive these effects, such as DNA methylation.  
Methylation marks at cytosine residues, typically found at cytosine phosphate 
guanine dinucleotides (CpGs), in the DNA are capable of regulatory control over gene 
activation or silencing and are additionally believed to help prevent alternative 
transcription start sites. These roles are dependent on location relative to gene 
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architecture (promoter, exon, intron, etc.). Because these heritable marks are capable of 
driving changes that may affect phenotype, they represent a logical candidate for a 
mechanism to explain the increased disease susceptibility in the offspring of older 
fathers. In this study, we have analyzed the age-associated sperm DNA methylation 
alterations that are common among the individuals in our study population to determine 
the magnitude of sperm DNA methylation changes over time and whether specific 




 Our results indicate that, in general, sperm DNA methylation marks are robust 
within individuals as they age, though there are alterations that occur. Based on our 
pyrosequencing analysis of long interspersed elements (LINE), global sperm DNA is 
significantly hypermethylated with age as previous data from our lab suggest (Figure 
4.1.) 17. In addition to this global change, we identified multiple regions of age-associated 
methylation alterations. We have identified intraindividual regional methylation 
alterations between paired samples (young and aged) that consistently occur within the 
same genomic windows in most or all of the donors screened. Remarkably, these 
alterations occur whether the individual collected the samples in their 20s and 30s or in 
their 50s and 60s. Using a sliding window analysis, coupled with regression analysis as 
an additional filter, we identified a total of 139 regions that are significantly 
hypomethylated with age (Log2ratio ≤-0.2) and 8 regions that are significantly 
hypermethylated with age (Log2ratio ≥0.2; Table 4.1).  
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Figure 4.1: Pyrosequencing results for the LINE-1 global methyaltion assay. The box plot 
depicts significantly increased average global methylation with age in paired samples 
from all 17 donors based on a two tailed t-test (p=0.028; A). Global methylation was also 
stratified based only on age at the time of collection for each sample from all 17 donors 
(a total of 34 samples with each donor represented twice). Linear regression analysis 
confirmed the significant increases in global sperm DNA methylation with age 
(p=0.0062; B). 
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Association	   DMR	  
Log2	  
Ratio	   FDR	   R2	  
ARC	   Gene	  Body	   North	  Shore	   N/A	   -­‐0.2433	   65.69	   0.1902	  
ATHL1	   Gene	  Body	  
Island/South	  
Shore	   N/A	   -­‐0.2932	   65.69	   0.1714	  
ATN1	   Promoter	   North	  Shelf	   N/A	   -­‐0.3702	   65.69	   0.4421	  
ATXN7L3	   Promoter	   North	  Shore	   N/A	   -­‐0.2158	   65.69	   0.3413	  
BEGAIN	   Promoter	   South	  Shore	   N/A	   -­‐0.2747	   65.69	   0.4085	  
BLCAP	   Gene	  Body	   North	  Shore	   N/A	   -­‐0.2366	   65.69	   0.4881	  
C1orf122	   Promoter	   North	  Shore	   N/A	   -­‐0.2272	   65.69	   0.5157	  
C6orf48	   Gene	  Body	   South	  Shore	   N/A	   -­‐0.2061	   65.69	   0.1544	  
CCDC114	   Promoter	   North	  Shore	   N/A	   -­‐0.3703	   65.69	   0.5512	  
CCDC144NL	  
Promoter	  /	  
Gene	  Body	   Island	   N/A	   0.2034	   65.69	   0.1989	  
CFD	   Promoter	   North	  Shore	   N/A	   -­‐0.2795	   65.69	   0.3099	  
CLIC1	   Gene	  Body	   South	  Shore	   N/A	   -­‐0.2159	   65.69	   0.2098	  
CNN1	  
Promoter	  /	  
Gene	  Body	   N/A	   N/A	   -­‐0.2591	   65.69	   0.2501	  
CNTNAP1	   Promoter	   North	  Shore	   RDMR	   -­‐0.2157	   65.69	   0.3904	  
DLL1	   Gene	  Body	  
Island/North	  
Shore	   N/A	   -­‐0.2937	   65.69	   0.1544	  
DOK1	   Promoter	   North	  Shore	   CDMR	   -­‐0.2528	   65.69	   0.4926	  
DRD4	   Gene	  Body	   Island	   N/A	   -­‐0.5705	   65.69	   0.3172	  
EFCAB4A	   Gene	  Body	   Island	   N/A	   -­‐0.3166	   65.69	   0.2888	  
ELANE	  
Promoter	  /	  
Gene	  Body	   North	  Shore	   N/A	   -­‐0.5163	   65.69	   0.1359	  
GAPDH	   Promoter	   North	  shore	   RDMR	   -­‐0.2191	   65.69	   0.2135	  
GET4	   Promoter	  
Island/North	  
Shore	   N/A	   -­‐0.2080	   65.69	   0.316	  





Shore	   N/A	   -­‐0.2399	   65.69	   0.3908	  
KCNF1	   Gene	  Body	   Island	   N/A	   -­‐0.3344	   65.69	   0.1838	  
KCNQ1	   Gene	  Body	  
Island/North	  
Shore	   N/A	   -­‐0.2991	   65.69	   0.2046	  
LOC154449	   Promoter	   North	  Shelf	   N/A	   -­‐0.2064	   65.69	   0.122	  
MIR22HG	   Gene	  Body	   North	  Shore	   N/A	   -­‐0.2347	   65.69	   0.2404	  
MPPED1	   Gene	  Body	   Island	   N/A	   -­‐0.2851	   65.69	   0.1553	  
N/A	   N/A	   HMM	  Island	   N/A	   -­‐0.2041	   65.69	   0.2629	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N/A	   N/A	   Island/North	  
Shore	  
N/A	   -­‐0.2363	   65.69	   0.3355	  
N/A	   N/A	   North	  Shore	   N/A	   -­‐0.3082	   65.69	   0.2066	  
N/A	   N/A	   Island/North	  
Shore	  
N/A	   -­‐0.3820	   65.69	   0.1795	  
PCOLCE	   Promoter	  /	  
Gene	  Body	  
North	  Shore	   N/A	   -­‐0.2438	   65.69	   0.1543	  
PITPNM1	   Promoter	   North	  Shore	   N/A	   -­‐0.2669	   65.69	   0.4935	  
PPP1R18	   Gene	  Body	   Island/North	  
Shore	  
N/A	   -­‐0.2754	   65.69	   0.3867	  
PRSS22	   Promoter	   South	  Shore	   N/A	   -­‐0.2486	   65.69	   0.5034	  
PYY2	   Promoter	  /	  
Gene	  Body	  
North	  Shore	   N/A	   -­‐0.3241	   65.69	   0.6317	  
SECTM1	   Gene	  Body	   Island	   N/A	   -­‐0.2568	   65.69	   0.3782	  
SYNE4	   Promoter	   North	  Shore	   N/A	   -­‐0.2383	   65.69	   0.5805	  
TBKBP1	   Gene	  Body	   Island	   N/A	   -­‐0.2449	   65.69	   0.4863	  
THBS3	   Promoter	  /	  
Gene	  Body	  
North	  Shore	   N/A	   -­‐0.2657	   65.69	   0.5953	  
TNXB	   Gene	  Body	   Island	   N/A	   -­‐0.3319	   65.69	   0.2436	  




N/A	   -­‐0.2767	   65.69	   0.2616	  




N/A	   -­‐0.2473	   65.69	   0.1876	  
KDM2B	   Promoter	   South	  Shore	   RDMR	   -­‐0.3003	   65.67	   0.241	  
NSG1	   Promoter	   North	  Shore	   N/A	   -­‐0.2899	   65.47	   0.5232	  
SEZ6	   Gene	  Body	   Island/North	  
Shore	  
N/A	   -­‐0.4530	   65.05	   0.43	  
LMO3	   Promoter	   N/A	   N/A	   -­‐0.3627	   64.24	   0.2074	  




N/A	   -­‐0.2148	   64.21	   0.3354	  
DAPK3	   Promoter	   North	  Shore	   RDMR	   -­‐0.3932	   63.18	   0.3728	  
N/A	   N/A	   Island/North	  
Shore	  
N/A	   -­‐0.3281	   62.21	   0.2824	  
N/A	   N/A	   South	  Shore	   N/A	   -­‐0.2993	   62.03	   0.125	  
NSMF	   Gene	  Body	   Island/North	  
Shore	  
N/A	   -­‐0.2249	   61.30	   0.329	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TOR4A	   Promoter	   Island/North	  
Shore	  
N/A	   -­‐0.3046	   61.09	   0.3998	  
LDLRAD4	   Promoter	   N/A	   N/A	   -­‐0.2502	   60.61	   0.264	  
N/A	   N/A	   North	  Shore	   RDMR	   -­‐0.2866	   58.83	   0.5618	  
PTPRN2_3	   Gene	  Body	   North	  Shore	   N/A	   -­‐0.2391	   58.31	   0.151	  
SSTR5	   Gene	  Body	   Island/North	  
Shore	  
N/A	   -­‐0.2381	   57.88	   0.1457	  
LOC134368	   Gene	  Body	   South	  Shore	   RDMR	   -­‐0.2695	   57.71	   0.292	  
GRB7	   Promoter	   N/A	   N/A	   -­‐0.2087	   57.48	   0.3144	  
GNB2	   Gene	  Body	   South	  Shore	   N/A	   -­‐0.2238	   57.45	   0.1312	  
SNHG1	   Promoter	   North	  Shore	   N/A	   -­‐0.2004	   57.39	   0.404	  
LOC653566	   Promoter	   N/A	   N/A	   -­‐0.2929	   56.31	   0.2672	  
N/A	   N/A	   HMM	  Island	   N/A	   -­‐0.2479	   56.06	   0.1969	  
PDE4C	   Gene	  Body	   Island/South	  
Shore	  
N/A	   -­‐0.2858	   55.53	   0.4673	  
DLGAP2	   Gene	  Body	   Island/North	  
Shore	  
N/A	   -­‐0.2109	   55.49	   0.1296	  
MRPL36	   Gene	  Body	   North	  Shore	   N/A	   -­‐0.2268	   55.34	   0.3998	  
NCOR2	   N/A	   HMM	  Island	   N/A	   -­‐0.2106	   55.34	   0.583	  
N/A	   N/A	   North	  Shore	   CDMR	   -­‐0.2107	   54.57	   0.1157	  
N/A	   N/A	   N/A	   CDMR	   -­‐0.2813	   52.81	   0.2763	  
KCNA7	   Promoter	   South	  Shore	   N/A	   -­‐0.3664	   52.24	   0.5066	  
CACNA1H	   Gene	  Body	   South	  Shore	   N/A	   -­‐0.2855	   51.96	   0.1695	  
IRS4	   Gene	  Body	   North	  Shore	   RDMR
CDMR	  
-­‐0.2273	   51.23	   0.2364	  
KRT19	   Promoter	   South	  Shore	   N/A	   -­‐0.2701	   51.08	   0.3463	  
LRFN2	   Gene	  Body	   North	  Shore	   RDMR	   -­‐0.2525	   51.08	   0.2967	  
WFDC1	   Gene	  Body	   Island	   N/A	   -­‐0.2966	   50.49	   0.2675	  
APBA2	   Promoter	   N/A	   N/A	   -­‐0.3989	   50.10	   0.3216	  
USP36	   Gene	  Body	   North	  Shore	   RDMR	   -­‐0.3108	   49.92	   0.2693	  
PAX2	   Gene	  Body	   South	  Shore	   N/A	   -­‐0.3545	   49.15	   0.2825	  
PTPRN2_1	   Gene	  Body	   North	  Shore	   N/A	   -­‐0.2828	   48.41	   0.3052	  
N/A	   N/A	   North	  Shore	   RDMR	   -­‐0.2138	   47.98	   0.4739	  
N/A	   N/A	   HMM	  Island	   N/A	   -­‐0.2144	   47.75	   0.2672	  




N/A	   -­‐0.2483	   47.55	   0.4327	  
 
 
  41 
















FAM86JP	   Promoter	   Island/North	  
Shore	  
N/A	   0.2012	   47.43	   0.2884	  
TTC7B	   Promoter	   South	  Shore	   N/A	   -­‐0.2192	   47.25	   0.5194	  
FAM86C2P	   Promoter	  /	  
Gene	  Body	  
Island	   N/A	   0.2310	   46.89	   0.2156	  
GRIN1	   Gene	  Body	   Island/North	  
Shore	  
N/A	   -­‐0.3017	   46.65	   0.2898	  
LFNG	   Gene	  Body	   South	  Shore	   N/A	   -­‐0.3641	   46.65	   0.1898	  
N/A	   N/A	   HMM	  Island	   N/A	   0.2835	   46.65	   0.3944	  
N/A	   N/A	   North	  Shore	   RDMR	   -­‐0.3885	   46.65	   0.5595	  




N/A	   -­‐0.2081	   46.39	   0.1542	  
N/A	   N/A	   South	  Shore	  	   RDMR	   -­‐0.3423	   46.34	   0.1679	  
N/A	   N/A	   Island/North	  
Shore	  
N/A	   -­‐0.2100	   46.34	   0.3924	  
SLC22A18AS	   Gene	  Body	   South	  Shore	   N/A	   -­‐0.2397	   46.34	   0.5081	  
PURA	   Promoter	   Island/North	  
Shore	  
N/A	   -­‐0.2042	   46.08	   0.4237	  
NFAT5	   Promoter	   North	  Shore	   RDMR	   -­‐0.2129	   46.05	   0.1748	  
DMPK	   Gene	  Body	   Island	   N/A	   -­‐0.3335	   46.04	   0.2442	  
LOC100133
461	  
Promoter	   North	  Shelf	   N/A	   -­‐0.4967	   46.04	   0.3899	  
N/A	   N/A	   Island/North	  
Shore	  
CDMR	   -­‐0.2369	   46.04	   0.4311	  
N/A	   N/A	   HMM	  Island	   N/A	   -­‐0.3640	   46.04	   0.2529	  
PTPRN2_2	   Gene	  Body	   Island/North	  
Shore	  
N/A	   -­‐0.2666	   46.04	   0.1169	  
PITX1	   Gene	  Body	   North	  Shore	   CDMR	   -­‐0.2952	   45.96	   0.1888	  
ARHGEF10	   Gene	  Body	   N/A	   N/A	   -­‐0.3564	   45.72	   0.2585	  
N/A	   N/A	   North	  Shore	   N/A	   -­‐0.7087	   45.72	   0.222	  
PALM	   Gene	  Body	   Island	   N/A	   -­‐0.2109	   45.72	   0.3631	  
C7orf50	   Gene	  Body	   North	  Shore	   N/A	   -­‐0.2133	   45.54	   0.1568	  
SEMA6B	   Gene	  Body	   Island/North	  
Shore	  
CDMR	   -­‐0.3163	   45.39	   0.3574	  
FOXK1	   Gene	  Body	   South	  Shore	   RDMR	   -­‐0.4457	   45.27	   0.4838	  
FAM86C1	   Promoter	  /	  
Gene	  Body	  
Island	   N/A	   0.2260	   45.18	   0.1453	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ADAMTS8	   Promoter	   South	  Shore	   N/A	   -­‐0.2193	   44.74	   0.5308	  
N/A	   N/A	   North	  Shore	   N/A	   -­‐0.2771	   44.67	   0.2686	  
EDARADD	   Promoter	   North	  Shore	   N/A	   -­‐0.2506	   44.52	   0.3686	  
FAM86B2	   Promoter	   Island	  	   N/A	   0.2238	   44.48	   0.2209	  
AGRN	   Promoter	   South	  Shore	   N/A	   -­‐0.5087	   44.46	   0.3049	  
LEMD2	   Promoter	   North	  Shore	   N/A	   -­‐0.2055	   44.46	   0.414	  




N/A	   0.2070	   44.27	   0.3698	  
MIR9-­‐3	   Promoter	   Island/North	  
Shore	  
N/A	   -­‐0.2235	   44.17	   0.4838	  
KRT7	   Promoter	   North	  shore	   N/A	   -­‐0.2041	   44.15	   0.276	  
NKX2	   Promoter	   Island/North	  
Shore	  
RDMR	   -­‐0.3287	   44.01	   0.3185	  
N/A	   N/A	   North	  Shore	   N/A	   -­‐0.2408	   43.86	   0.3225	  
N/A	   N/A	   North	  Shore	   RDMR	   -­‐0.3785	   43.86	   0.6517	  
N/A	   N/A	   North	  Shore	   RDMR	   -­‐0.3876	   43.56	   0.3218	  
USP6NL	   Gene	  Body	   Island	   N/A	   -­‐0.4037	   43.54	   0.1384	  
N/A	   Promoter	   North	  Shore	   N/A	   -­‐0.2067	   43.22	   0.3973	  
N/A	   N/A	   Island	   N/A	   -­‐0.2748	   42.66	   0.5203	  
NBLA00301	   Gene	  Body	   North	  Shore	   RDMR	   -­‐0.2964	   42.35	   0.5779	  
AJAP1	   Gene	  Body	   South	  Shore	   RDMR	   -­‐0.3908	   42.06	   0.1215	  
CRYBA2	   Gene	  Body	   North	  Shore	   N/A	   -­‐0.2093	   42.06	   0.587	  
CTF1	   Promoter	   South	  Shore	   N/A	   -­‐0.2488	   42.06	   0.501	  
FOXF2	   Gene	  Body	   South	  Shore	   RDMR
CDMR	  
-­‐0.2036	   41.96	   0.3976	  
MAP4K1	   Promoter	   North	  Shore	   N/A	   -­‐0.2117	   41.91	   0.3082	  
N/A	   N/A	   HMM	  Island	   N/A	   -­‐0.2422	   41.86	   0.2107	  
BCL11A	   Gene	  Body	   N/A	   N/A	   0.2415	   41.79	   0.2955	  
N/A	   N/A	   North	  Shore	   RDMR	   -­‐0.2307	   41.76	   0.529	  
LONP1	   Gene	  Body	   Island	   N/A	   -­‐0.2769	   41.19	   0.3134	  
N/A	   N/A	   HMM	  Island	   N/A	   -­‐0.2885	   41.19	   0.3396	  
TBC1D10A	   Gene	  Body	   North	  Shore	   N/A	   -­‐0.3085	   41.19	   0.528	  
CALCA	   Gene	  Body	   North	  Shore	   N/A	   -­‐0.2781	   40.89	   0.2362	  
DNMT3B	   Gene	  Body	   South	  Shore	   RDMR	   -­‐0.3683	   40.89	   0.2687	  
VAX2	   Gene	  Body	   North	  Shore	   RDMR	   -­‐0.2485	   40.89	   0.3199	  
ZFPM1	   Gene	  Body	   Island	   N/A	   -­‐0.2848	   40.76	   0.1458	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OXLD1	   Gene	  Body	   North	  Shore	   N/A	   -­‐0.2737	   40.60	   0.3644	  
FSCN1	   Gene	  Body	   South	  Shore	   RDMR	   -­‐0.3639	   40.31	   0.3546	  
FXYD6	   Promoter	   South	  Shore	   N/A	   -­‐0.3141	   40.31	   0.2952	  
NADK	   Promoter	   South	  Shore	   RDMR	   -­‐0.2196	   40.31	   0.3951	  
PARP12	   Gene	  Body	   North	  Shore	   CDMR	   -­‐0.2035	   40.31	   0.3821	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  The average called window is approximately 887 base pairs in length and contains 
an average of 5 CpGs with no fewer than 3 in any significant window. Of the 139 
hypomethylated regions, 112 are associated with a gene (at either the promoter or the 
gene body) and of the 8 hypermethylated regions, 7 are gene associated. In one case, we 
identified 3 significantly hypomethylated windows within a single gene (PTPRN2). Thus, 
there were a total of 110 genes with age-associated hypomethylation.  
The significant loci identified in our analyses are located at various genomic 
features. The majority of regions that displayed age-associated hypomethylation events 
occur at CpG shores and not in CpG islands themselves, whereas hypermethylation 
events are more commonly associated with CpG islands (Figure 4.2A-B). In most cases, 
age-associated methylation alterations occur at regions that likely impact gene 
transcription (gene bodies, promoters). However, our data also indicate that these 
alterations are relatively subtle, with hypomethylation events displaying an average intra-
individual % methylation decrease (calculated as a β-value for array data with values 
between 0 and 1) of approximately 0.039, ranging from 0.01 to 0.104 between paired 
samples (young and aged). Similarly, for age-associated hypermethylation events, the 
average % methylation increase was approximately 0.032 (Figure 4.2C). Importantly, 
these alterations all occur in windows with an average initial % methylation of <0.6 at the 
first collection and the majority (68% of hypomethylation events and 50% of 
hypermethylation events) are also considered to have intermediate methylation based on 
conventional standards (β-value between 0.2 and 0.8).  
We additionally analyzed the colocalization of windows of age associated 
methylation alterations with known regions of nucleosome retention in the mature sperm,  
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Figure 4.2: The attributes of significant windows identified in our study for both 
hypermethylation events and hypomethylation events (A and B, respectively). These 
designations are based on UCSC annotation at the regions of interest. Average β-values 
for all significant windows (hypomethylation and hypermethylation events) for both aged 
and young (C). Average decrease in β-value for intra-individual hypomethylation events 
was approximately 3.9% and for hypermethylation events was 3.2%. We also 
investigated the colocalization of nucleosomes (every region of known histone retention) 
as well as histone modifications (H3K4 methylation, and H3K27 methylation) with our 
windows of interest (D). Hypermethylation events were less frequently associated with 
all retained histones (nucleosomes) and loci with H3K27 methylation when compared to 
hypomethylation events based on Fisher’s Exact Test (p=0.002; p=0.0107). Co-
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as well as regions where specific histone modifications are found based on previous work 
from our laboratory 12. We found that approximately 88% of regions that are 
hypomethylated with age are found within 1 kb of known nucleosome retention sites in 
the mature sperm (Figure 4.2D.). Interestingly, loci that are hypermethylated with age are 
far less frequently found in regions of histone retention, with only approximately 37.5% 
being associated with sites where nucleosomes are found. This difference was significant 
based on a Fisher’s Exact test. Similarly, 23% of loci with age-associated 
hypomethylation are associated with H3K4 methylation and 45.3% are associated with 
H3K27 methylation. The same colocalization is very rare with hypermethylaiton events. 
Additionally, we analyzed chromosomal enrichment of these significant marks to 
determine if there are specific chromosomal regions that are more susceptible to age-
related methylation alterations. We found a random distribution of significant age-
associated methylation alterations throughout the entire genome with no one 
chromosomal region being significantly enriched (Figure 4.3.).  
 
 Sequencing Analysis 
 A representative group of windows was selected for targeted sequencing to 
confirm that the CpGs tiled on the array were representative of the entire CpG content 
within the windows of interest. Both young and aged samples from each donor were 
analyzed and compared at these specific loci. In 20 of the 21 gene regions that were 
analyzed, the array and MiSeq data were similar in both direction and relative magnitude 
(Figure 4.4.). In the one case that did not show a similar trend (hypomethylation with age 
by array and no change by MiSeq), the amplicon was outside the region of the two CpGs  
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Figure 4.3:  Chromosomal loci of each altered region are depicted where blue marks are 
hypomethylation events and red marks are hypomethylation events (A). The Correlation 
Maps app on the USeq platform was used to locate any specific chromosomal enrichment 
of altered methyaliton windows. Specifically, the application called any 100kb region 
where at least two significantly altered methylation marks were found. All called 
chromosomal enrichment regions are displayed (B) though none were found to be 
significantly enriched over the background.  
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Figure 4.4:  Comparison of MiSeq results to our array results at 21 representative regions. 
Because beta-values and fraction methylation are generated in a different manner (array 
vs. sequencing, respectively) they are not directly comparable. For this reason, we 
compared the % difference for each loci and each technology. This is accomplished by 
the following equation: % difference = (aged value/young value) – 1. 
 
that drove the significance of the window. When comparing the methylation of the 
approximately 300bp amplicon to the CpG tiled on the array in that same region only, 
and not the array CpGs over the entire 1000bp window, the data are in agreement. Taken 
together, the sequencing run confirmed that our array data are a good representation of 
the methylation status at all CpGs in our regions of interest.  
 
GO Term Pathway and Disease Association Analysis 
 The genes affected by the age-associated methylation alterations (those that have 
alterations that occur at their promoter, or gene body) were analyzed by Pathway, GO, 
and disease association analysis. The results indicate that no one GO term or Pathway is 
significantly altered in our gene group. Similarly, there were no significant diseases or 
disease classes associated with the genes identified in this study based on results of the 
disease association tool on DAVID. However, the most significant disease hits (those that 
 
  49 
were significant prior to multiple comparison correction) have both been suggested to 
have an increased incidence in the offspring of older fathers, namely myotonic dystrophy 
and schizophrenia 2,7. To directly investigate the disease association(s) in our set of 
genes, we searched the National Institute of Health’s (NIH) genetic association database 
(GAD), which is utilized in DAVID’s disease association analysis algorithm. We 
investigated all 117 genes that were determined to have age-associated methylation 
alterations (110 hypomethylated; 7 hypermethylated) for their various disease 
associations. A total of 46 genes from our group have been confirmed to be associated 
with either a phenotypic alteration or a disease based on GAD annotation. We identified 
4 diseases that had known associations with at least 3 of our genes (diabetes mellitus, 
hypertension, bipolar disorder, and schizophrenia). To further investigate these 
associations, we analyzed the frequency of genes associated with these 4 diseases in our 
gene set and compared it to their frequency in all 11,306 genes known to be associated 
with either a phenotypic alteration or a disease. This analysis revealed that both bipolar 
disorder and schizophrenia were more frequently associated with regions prone to age-
related methylation change than the background set of genes based on Fisher’s Exact test 
(p = 0.001 and p = 0.005, respectively; Figure 4.5). The frequency of genetic association 
between our gene set and the background gene set was statistically similar for both 
hypertension and diabetes mellitus.  
 
Discussion 
Herein we report alterations to sperm DNA methylation associated with age. 
Interestingly, our data are in contrast with previous reports of age-associated methylation  
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Figure 4.5: The frequency of disease associations within our gene set was analyzed and 
compared to the frequency of disease associations for all genes known to be associated 
with at least a single disease based on GAD annotation. Schizophrenia, bipolar disorder, 
diabetes mellitus, and hypertension were selected as there were at least 3 genes in our 
small set of identified genes that are associated with these diseases. Only bipolar disorder 
and schizophrenia were more frequently associated with our identified genes then the 
background set of genes based on Fisher’s Exact test with p-values of 0.001 and 0.005 
respectively.  The frequency of genes associated with hypertension and diabetes mellitus 
in the two groups was statistically similar.    
 
alterations in somatic cells. Recent literature suggests age-associated global 
hypomethylation with regional (gene associated) hypermethylation in somatic tissue 18. In 
contrast, our data reveal age-associated hypermethylation globally with a strong bias 
toward hypomethylation regionally. This is less surprising when we take into account the 
fact that sperm are known to have other age-associated modifications that defy 
convention (i.e., telomere length) 19-21. Intriguingly, while the methylation alterations 
reported herein are relatively subtle, they are strikingly significant and are common 
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among individuals at various ages and intervals between collections, suggesting that these 
regions are consistently altered over time in a linear fashion. Importantly, it appears that 
many significantly altered regions are at loci that may contribute to various diseases 
known to have increased incidence in the offspring of older fathers. Coupling these with 
our data demonstrating that no one GO term or pathway is up- or down-regulated in the 
sperm as a result of the aging process suggests that the alterations we observed are the 
result of regional genomic susceptibility to methylation alteration. This hypothesis also 
comports well with the linear nature of the alterations we observed. While the nature of 
this susceptibility is difficult to elucidate, it may be related to chromatin architecture. 
 
Localization of Altered Regions 
To investigate the attributes of regions that we determined to be most susceptible 
to methylation alterations, we evaluated the colocalization of significantly altered loci in 
our study with regions of nucleosome retention in the mature sperm. It appears that 
hypomethylation events are most commonly associated with sites of nucleosome 
retention. Interestingly, this same colocalization was not seen with hypermethylation 
events. Though colocalization patterns are significantly different between the 
hypomethylation and hypermethylation events, it should be noted that the sample size is 
quite small in the hypermethylation group (8 significant windows). It should also be 
noted that while the colocalization of histones and the hypomethylation events we 
observed in our study are significant, the methylation marks observed are likely 
established earlier in spermatogenesis and thus may not be affected by the nucleosome 
architecture in the fully matured sperm. In addition, the alterations identified in this study 
are not localized everywhere that histones are retained; thus, nucleosome retention alone 
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cannot be the independent driving force of regional susceptibility to methylation 
alterations.  
Recent literature suggests an interesting hypothesis of “selfish spermatogonial 
selection” that may have application in this study as well 22. Briefly, the hypothesis states 
that some gene mutations that are causative of abnormalities in the offspring are 
beneficial to spermatogenesis and become enriched throughout the aging process in 
spermatogonial stem cells. Thus, sperm carrying these mutations become more frequent 
in the population to the detriment of the offspring. Similarly, it is possible that the age-
associated methylation alterations we have identified may be in regions that are important 
to spermatogenesis and thus would be selected for. The hypomethylation events that are 
selected for could occur as a result of either active or passive demethylation. For 
example, regional transcription activity at loci important in spermatogenesis would likely 
be accompanied by a relaxed chromatin structure that could result in increased frequency 
of DNA damage over time. Established methylation marks located within this region 
could then be passively removed through repair mechanisms in the developing sperm. If 
the removal of this mark is either beneficial or has no effect on spermatogenesis, it will 
persist, and over time, similar marks could accumulate at nearby CpGs, ultimately 
leading to the profile we identified in our study. Alternatively, active enzymatic removal 
of methylation marks in the sperm might drive age-associated methylation changes. For 
this to be mechanistically plausible, we would have to assume that hypomethylation in 
the windows we identified is always beneficial to spermatogenesis. While either of these 
mechanisms is plausible, it is likely that the effects we have identified involve some 
combination of both.  
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The mechanics of hypermethylation events with age are more difficult to 
elucidate, as this, by definition, has to be an active targeted process involving 
methyltransferase enzymes. However, some evidence from this study indicates DNA 
sequence may be an important driver of age-related hypermethylation. Of the 7 windows 
that we identified with gene-associated hypermethylation with age, 4 are associated with 
the FAM86 family of genes that are categorized not by protein function or genomic 
location but sequence similarity. This strongly suggests that, at least in part, age-
associated hypermethylation events at specific loci are driven, either directly or 
indirectly, by DNA sequence. Interestingly, this family of genes (FAM86) with unknown 
function has recently been categorized with a larger family of methyltransferase genes, 
though it remains unclear what the FAM86 target(s) is/are (DNA, Histone, other proteins, 
etc.). Taken together, the mechanisms that drive age-related methylation alterations in the 
sperm remain elusive, but likely involve both active and passive methylation 
modification. 
Biological Significance 
It is important to consider two questions in determining the biological impacts of 
the identified methylation changes in this study. First, are the methylation changes 
described herein capable of transcriptional alterations? Second, are these methylation 
changes capable of avoiding embryonic methylation reprogramming? Regardless of the 
mechanism by which these methylation marks are altered in the sperm over time, it is 
striking that these changes occur with such consistency between individuals and have 
such a tight association with age. One limitation of these findings, however, is the 
magnitude of alterations we have discovered. As described earlier, the average intra-
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individual alteration at any given window was approximately a change of 3.9%. Though 
this seems relatively small, when expanded to include the possible reproductive years in a 
male (approximately age 20-60), the change would be 10-12%. Importantly, because of 
the heterologous nature of the sperm population, a change of this magnitude in average β-
value over a window including multiple CpGs needs to be considered in two different 
ways. First, a decrease of 10-12% reflects a complete methylation erasure (from fully 
methylated to fully demethylated at all CpGs within a given window) in 10-12% of the 
sperm population. The second possibility is that the observed β-value alterations reflect 
changes to random CpGs within windows of susceptibility in all sperm, which would 
manifest as hemimethylation in the region of interest in all sperm in the population. The 
resultant 10-12 % change in methylation within every individual sperm (effectively 1 out 
of every 10 CpGs are demethylated) suggests that every sperm carries similar, more 
subtle, alterations within these windows on average. It is likely that the degree and 
distribution of these alterations throughout the entire sperm population varies greatly 
depending on the region of interest and the demethylation process (active or passive). The 
resultant epigenetic landscape alterations in either case may contribute to disease 
susceptibility in the offspring despite the small degree of change across the whole 
population though the increased risk to the offspring may be relatively small. Figure 4.5 
gives a breakdown the alterations seen at two representative loci, DRD4 and TNXB. 
The heritability of such marks is more difficult to elucidate mainly because the 
current study does not directly address this question. However, this issue needs to be 
addressed as the identified age-associated methylation alterations in the mature sperm 
may be removed through the embryonic demethylation wave. It should be noted that 
 
  55 
despite the fact that there is no direct evidence of methylation alteration heritability at the 
specific loci presented in this work, the observed age-associated changes at regions 
known to be of significance in diseases with increased incidence in the offspring of aged 
males is striking and warrants further study. The intriguing localization of these 
alterations suggests that the methylation profile in the mature sperm, at specific loci, 
either contributes to the increased incidence of associated abnormalities in the offspring 
or that they reflect (are downstream of) changes that are actually causative of the 
associated abnormalities in the offspring. Moreover, it has been previously proposed that 
epigenetic alterations are among the most likely candidates to transmit such 
transgenerational effects, and we have identified methylation alterations that appear 
capable of contributing to the various pathologies associated with advanced paternal age. 
Despite this, future work must still be performed to determine the real impact these marks 
have on transcription and thus phenotype and disease. Taken together, these subtle yet 
highly significant, age-associated alterations to the sperm methylation profile are 
intriguing because of their location and consistency, but more work is required to 
elucidate the biological impact of these marks.  
There are many genes identified in our study that, if biologically affected, may 
result in pathologies in the offspring. Dopamine receptor D4 (DRD4) is one of the most 
influential genes in the pathology of both schizophrenia and bipolar disorder as well as 
many other neuropsychiatric disorders 23,24. Interestingly, the entire DRD4 gene itself is 
strongly hypomethylated with age (Figure 4.6). TNXB has also been suggested to be 
associated with schizophrenia based on multiple studies, though the data are controversial 
25,26, and virtually the entire 1st exon of TNXB is hypomethylated with age. Additionally,  
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Figure 4.6: Descriptive statistics are presented for both TNXB and DRD4; 2 regions of 
representative methylation alterations. The alignment track for each gene is displayed in 
Integrated Genome Browser (IGB) with the associated false discovery rate (FDR) 
denoting the significance of the change and the and absolute log 2 ratio reflecting the 
magnitude of the alteration (A,B). Scatter plots for each sample from all 17 donors (a 
total of 34 samples with each donor represented twice) revealed a significant decrease in 
methyalation with age at both DRD4 and TNXB (p=0.0005 and p=0.003, respectively; 
C,D). 
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DMPK, a gene identified in our study, is known to be associated with myotonic 
dystrophy, a disease for which advanced paternal age is a risk factor 7. In fact, increases 
in trinucleotide repeats in DMPK are believed to be the cause of myotonic dystrophy type 
1. Importantly, previous data suggest that altered methylation marks may affect 
trinucleotide instability 27. These examples represent only a portion of the genes that were 
identified in our study and support the hypothesis that age-associated DNA methylation  
alterations in sperm may play a role in the etiology of various diseases associated with 
advanced paternal age.  
 
Future Directions 
There are 2 important findings in this study. First, that there are any age-
associated alterations common among such a varied study population is remarkable. 
Specifically, age-associated methylation alterations occur in the sperm regardless of 
whether the ages between collections are approximately 20 to 30 years of age or 50 to 60 
years of age. Second, the increased frequency of genes associated with bipolar disorder 
and schizophrenia in our study when compared to all genes associated with disease 
provides intriguing insight into the increased susceptibility of these specific disorders in 
the offspring of older fathers. Though frequently hypothesized, this work comprises, to 
the best of our knowledge, the first direct evidence suggesting the plausibility of 
epigenetic alterations in the sperm of aged fathers influencing, or even causing, disease in 
the offspring. Because of the nature of the unique sample set we have utilized in this 
study, future work is needed to directly address a number of questions. Are methylation 
alterations, similar to those seen in our study, causative of neuropsychiatric disease? Can 
the methylation marks we observe in our study avoid embryonic demethylation? Future 
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targeted work is required to directly address these questions to enable us to determine the 
role that these altered methylation marks play in the increased incidence of various 




 Under an Institutional Review Board approved study, our laboratory has accessed 
samples from 17 sperm donors (of known fertility) that were collected in the 1990s. 
These donors provided an additional semen sample in 2008, enabling the evaluation of 
intraindividual changes to sperm DNA methylation with age. These samples are referred 
to as young (1990s collection) and aged (2008 collection) samples. The age difference 
between each collection varied between 9 and 19 years, and the age at first collection 
(“young” sample) was between 23 and 56 years of age. 
At every collection, donors were required to strictly follow the University of Utah 
Andrology Laboratory collection instructions, which includes abstinence time of between 
2 and 5 days. The whole ejaculate (no sperm selection method was employed) collected 
at each visit was frozen in a 1:1 ratio with Test Yolk Buffer (TYB; Irvine Scientific, 
Irvine, CA) and stored in liquid nitrogen prior to DNA isolation. Samples were thawed 
and the DNA was extracted simultaneously to decrease batch effects. Prior to DNA 
extraction, samples underwent somatic cell lysis by incubation in a somatic cell lysis 
buffer (0.1% SDS, 0.5% Triton X-100 in DEPC H2O) for 20 min on ice to eliminate 
somatic cell contamination. Samples were visually inspected following lysis to ensure the 
absence of all potentially contaminating cells before proceeding. Following somatic cell 
lysis, sperm DNA was extracted with the use of a sperm-specific extraction protocol used 
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routinely in our laboratory 28. Briefly, sperm DNA was isolated by enzymatic and 
detergent-based lysis followed by treatment with RNase and finally DNA precipitation 
using isopropanol and salt, with subsequent DNA cleanup using ethanol.  
  
Microarray Analysis 
Each of the paired samples for the 17 donors (a total of 34 samples) were 
subjected to array analysis using the Infinium HumanMethylation 450 Bead Chip micro-
array (Illumina, San Diego CA). Extracted sperm DNA was bisulfite converted with EZ-
96 DNA Methylation-Gold kit (Zymo Research, Irvine CA) according to manufacturer’s 
recommendations. Converted DNA was then hybridized to the array and analyzed 
according to Illumina protocols at the University of Utah genomics core facility. Once 
scanned and analyzed for methylation levels at each CpG, a ß-value was generated by 
applying the average methylated and unmethylated intensities at each CpG using the 
calculation: ß-value = methylated/(methylated + unmethylated). The resultant ß-value 
ranges from 0 to 1 and indicates the relative levels of methylation at each CpG with 
highly methylated sites scoring close to 1 and unmethylated sites scoring close to 0. 
Basic descriptive analyses of the microarray data were performed using Partek 
(St. Louis MO). More in-depth analysis was performed using the USeq platform with the 
application Methylation Array Scanner which identifies regions of altered methylation 
that are common among individuals utilizing a sliding window analysis. Briefly, paired 
data from each donor (young and aged) were subjected to a 1000 base pair sliding 
window analysis where regions of altered methylation with age that are common among 
donors were called by Wilcoxon Signed Rank Test. To prevent the influence of outliers 
in the data set, methylation for a specific window was reported as a pseudo-median and 
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differences between the young and aged sample are reported as log2 ratios. Two 
thresholds were applied to identify windows with significant differential methylation.  A 
Benjamini Hochberg corrected Wilcoxon Signed Rank Test FDR of >=0.0004 and an 
absolute log2 ratio >= 0.2. To confirm the significance of each of the called windows, we 
subjected the mean β-value within the window for each donor (young and aged samples) 
to a paired t-test. Following this initial filter, we additionally subjected each significant 
window to a regression analysis to determine the relationship between age and mean 
methylation within each window. Regression analysis and paired t-tests were performed 
using STATA 11 software package. 
 
Sequencing Analysis 
 Each sample was additionally subjected to targeted methylation sequencing at loci 
determined to be of interest based on microarray analysis. This step was designed to 
confirm the array results and to provide greater depth of coverage of the CpGs in the 
windows of interest. Primers for 21 loci were designed using MethPrimer (Li Lab, 
UCSF). PCR was performed on samples following sperm DNA bisulfite conversion with 
EZ-96 DNA Methylation-Gold kit (Zymo Research, Irvine CA). PCR products were 
purified with QIAquick PCR Purification Kit (Qiagen, Valencia CA) and were pooled for 
each sample. The Pooled products were delivered to the Microarray and Genomic 
Analysis core facility at the University of Utah for library prep which included shearing 
of the DNA with a Covaris sonicator to generate products of approximately 300 base 
pairs, in preparation for 150 bp paired end sequencing, and the addition of sample-
specific barcodes for all 34 samples. Multiplex sequencing was then performed on a 
single lane on the MiSeq platform (Illumina, San Diego CA). 
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Pyrosequencing Analysis 
Each sample was subjected to pyrosequencing analysis of a portion of the LINE-1 
repeatable element for the purpose of confirming previously determined global 
methylation changes with age. Briefly, isolated sperm DNA samples were submitted to 
EpigenDx (Hopkinton, MA) for the pyrosequencing analysis. Qiagen’s PyroMark LINE1 
kit was used to determine methylation status at each CpG investigated with the assay. 
The experiment was performed based on manufacturer recommendations.  
 
GO Term / Pathway / Disease Association Analysis 
GO term Analysis was performed with Gene Ontology Enrichment Analysis and 
Visualization Tool (GOrilla; cbl-gorilla.cs.technion.ac.il). Pathway and disease 
association analysis was performed on the Database of Annotation, Visualization, and 
Integrated Discovery (DAVID; david.abcc.ncifcrf.gov) v6.7. Additional disease 
association analysis was performed directly on the National Institute of Health’s Genetic 
Association Database (GAD; geneticassociationdb.nih.gov). 
  
Additional Statistical Analyses 
Fishers Exact test was used to determine the differences in frequencies of genes 
associated with particular diseases between our significant gene group and a background 
group. This analysis was also used to detect the differences in frequencies of windows 
that were found in regions of histone retention in the hypomethylation group and the 
hypermethylation group. Additionally, regression analysis was utilized to determine 
relationships between age and methylation status at various loci. STATA software 
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Herein we have described the first direct evidence that regional age-associated 
epigenetic alterations to the sperm provide a plausible, though not yet fully elucidated, 
mechanism for the increased incidence of neuropsychiatric disorders in the offspring of 
older fathers. We will further discuss the social and biological implications of the 
“paternal age effect” and the contribution of the sperm epigenome to this effect, as well 
as the possible clinical significance of age-associated epigenetic alterations and important 
future directions that may, one day, facilitate the development of epigenetic diagnostic 
testing to provide helpful insight for couples of advanced reproductive age in their family 
planning decisions.   
  
The Paternal Age Effect: Role of the Sperm Epigenome 
There is a striking trend of delayed parenthood in developed countries, likely as a 
result of socioeconomic and secular pressures as well as increased rates of divorce and 
remarriage 1,2. This trend is justified by increasing life expectancies; however, this delay 
may have undesirable impacts on fertility, pregnancy outcome, and even offspring health. 
There are very well-established negative consequences associated with advanced 
maternal age and fertility, pregnancy outcomes, and offspring abnormalities while the 
issue of male age has long been considered less significant. However, recent evidence has 




more pronounced when coupled with a female partner of advanced reproductive years. 
Specifically, as outlined earlier, advanced paternal age is associated with increased 
incidence of neuropsychiatric disorders, trinucleotide repeat associated diseases and some 
forms of nervous system and hematological cancers 3-13.  
This is particularly troubling when considering that the trend of increased paternal 
age at conception continues to increase with no indication of reversal and that some of 
the undesirable effects may extend, or even be amplified, over multiple generations 14. 
Intriguingly, concomitant with increasing delays in parenthood is increased incidence of 
neuropsychiatric disease 15. Specifically, data presented from multiple groups at a recent 
conference in Switzerland all demonstrated increased incidence of psychoses and/or 
schizophrenia in Australian, Canadian, and English populations 15. While these data 
remain controversial, the apparent trend of increasing cases of neuropsychiatric disorders 
taken together with the data demonstrating increased risk of developing these in the 
offspring of older fathers and the trend of delayed parenthood supports the growing 
epidemiological data suggesting an association between the age of the father and the 
likelihood of neuropsychiatric disease in the offspring.  
While it is known that the incidence of these various disorders is associated with 
advanced paternal age, the actual mechanism or, more likely, mechanisms that drive this 
process are poorly understood and in many cases remain entirely elusive. Interestingly, 
many have hypothesized that epigenetic modifications, in particular DNA methylation 
alterations, are capable of driving such subtle changes in the father’s germ cells that 
ultimately may lead to altered phenotype in the offspring. Our array and sequencing data 




linear, and relatively predictable, fashion at very consistent loci. This suggests that some 
regions of the DNA are more susceptible to methylation alterations than are others and 
that genes or regulatory features that lie in these regions are, in turn, more susceptible to 
age-associated transcriptional changes resultant from epigenetic modifications that may 
then contribute to the increased incidence of abnormalities in the offspring. This finding 
is remarkable because of its consistency between individuals throughout varied periods of 
aging and may prove to be very important to our understanding of offspring phenotypic 
alterations, and the study of transgenerational inheritance.  
It is important to note that for the alterations we have discovered to have impact 
on the offspring, these aberrant methylation marks would have to escape embryonic 
methylation erasure and reestablishment. If these altered regions are capable of such 
demethylation avoidance and are able to persist and contribute to offspring abnormalities, 
then it is likely the alterations described herein may have effect beyond a single 
generation. In brief, if the altered marks are heritable and escape embryonic 
reprogramming, then they may accumulate over multiple generations, further 
compounding the issue of the paternal age effect. Indeed, available data suggest that the 
effect of advanced paternal age may have impact on grandchildren and not just the 
offspring of older fathers 5,14. Thus, while the alterations we have detected are relatively 
subtle, it is easy, by extrapolating these effects over multiple generations, to understand 
that the negative impacts of advanced paternal age may be significantly compounded 
over time. 
It is clear that advanced paternal age does have an impact on the offspring, though 




our data, it also appears that the described impacts on offspring phenotype may be 
mediated by epigenetic alterations, specifically DNA methylation changes in discrete 
genomic windows. While not definitive, these data provide us with strong evidence 
suggesting that sperm DNA methylation alterations that accumulate with age may impact 
offspring phenotype. 
 
Possible Clinical Implications 
While the study of age-associated sperm epigenetic alterations and their 
contribution to altered offspring phenotype is in its infancy, there are possible future 
clinical applications.  
  
Diagnostic Testing 
Epigenetic diagnostic tests on sperm DNA is difficult for many reasons. In terms 
of the future offspring, the most relevant and important information cannot be directly 
determined, specifically the epigenetic profile of the single sperm that fertilizes the egg. 
While it is not a possible to analyze this one cell, an understanding of the entire sperm 
population’s epigenetic profile can inform patients of increased risks, which may be of 
value particularly for older patients where increased risks are more likely.  
Altered methylation marks in the sperm that either contribute to, or are causative 
of, phenotypic alterations in the offspring cannot be treated, as targeted epigenetic 
therapy is currently unrealistic. However, it is not unreasonable to imagine epigenetic 
diagnostic testing on the germ cells of the father, probing regions that are known to be 
altered with age in sperm DNA and that are causative of, or contribute to, offspring 




an advanced reproductive age of possible increased risks. It is likely, and our data 
suggest, that at some loci known to undergo age-associated epigenetic alteration, the 
magnitude of changes varies significantly between individuals, possibly a result of 
lifestyle differences (diet, exercise, tobacco/alcohol use, etc.). Thus, while all aged 
individuals may have an increased risk of siring offspring with the previously described 
disorders, some may have a particularly high risk compared to others and this information 
could aid patients in making important family planning decisions.  
 
Preemptive Measures 
Recent media coverage of the paternal age effect on offspring has increased not 
only the scientific communities’ interest in the topic, but also the general public’s. It is 
important that accurate information regarding the risks of fathering children at an 
advanced age be presented to men early enough that they are able to make well-informed 
decisions. It is again important to note that while the increased relative risk associated 
with advanced age is quite striking, the absolute risk to the offspring remains fairly low. 
Regardless, many individuals would still prefer to avoid this risk if possible. With this in 
mind, there are a few possible interventions that can be and, in some cases, are already 
being explored by physicians and their patients.  
Currently, there are a number of steps that can be taken by concerned individuals 
to avoid the possible negative consequences of fathering children at an advanced age. 
These options have varying degrees of effectiveness. Likely, the most effective method is 
simply starting families at an age earlier than individuals had previously anticipated 
through natural conception, though this may be unrealistic for many as a result of 




such as cryopreservation of sperm at a young age, as a possible way to avoid the negative 
consequences of advanced age on the sperm. In fact, many private tissue banks now 
advertise such services. While this may be a beneficial, we have little data regarding the 
negative impacts of cryopreservation on the sperm and particularly on the offspring. 
Additionally, the reproductive therapies used to generate offspring with the 
cryopreserved samples may introduce unwanted risks as well. While there are little data 
to support this practice, sperm cryopreservation introduces little to no risk to the 
individual storing the sample and is relatively inexpensive. As a result, it is not 
unreasonable for a physician to explore such options, though the patients must be well 
informed of the risks and benefits. 
Taken together, much more information is needed to increase our understanding 
the paternal age effect and the influence of the sperm epigenome in the process. With a 
more thorough understanding of these issues, we can better evaluate the benefit of 
various diagnostic tests or preemptive measures designed to decrease the risks of 
advanced paternal age and the impacts on offspring phenotype.  
  
Future Directions 
Much work is still required to gain a more complete understanding of the 
epigenetic alterations in sperm that are capable of phenotypic alterations in the offspring. 
We have identified a number of genomic regions that both undergo methylation 
alterations with age and are important in various diseases known to have increased 
incidence in the offspring of older males. To determine if these marks can contribute to 





What is the impact of altered methylation profiles at our regions of interest? To 
completely understand the alterations we have seen and their impact on offspring 
phenotype, we have to determine if these alterations are associated with transcriptional 
changes. Future work can target either paired samples, as we did in our study, from 
multiple individuals (young and aged) or a large number of individuals of various ages 
and identify both the common methylation alterations that occur with age and the 
associated changes to transcriptional activity. Ideally, future work would also include 
offspring methylation status and transcriptional activity from multiple tissues in the 
offspring. 
Do the altered methylation marks seen in sperm escape embryonic 
demethylation? To effectively accomplish this, an aged animal model should be used. 
Sperm from aged mice and young mice could be analyzed to confirm our findings 
(windows of altered methylation at analogous regions). The presence or absence of 
similar methylation marks in the offspring can then be determined. To increase the rigor 
of such a study, a highly polymorphic strain of mouse could be mated with a common 
background strain to assist in determining parent of origin, effectively enabling the 
researcher to follow changes on the paternal DNA with a great degree of confidence.  
Do methylation perturbations contribute to neuropsychiatric disorders? Large 
epidemiological studies that identify epigenetic changes in very well-defined groups 
(bipolar disorder, schizophrenia, autism, etc.) are needed. These epigenome-wide studies 
have the capacity to identify both striking and subtle associations. The identification of 
even mildly altered genomic loci that are commonly perturbed in humans with specific 




increased incidence of these diseases in the offspring of older fathers. Such a project was 
recently initiated for the study of Autism. Intriguingly, this specific study will utilize the 
450K array as was used in our study; thus, our two data sets can be directly compared to 
determine any similar findings.  
 
Conclusion 
Our data represent, to the best of our knowledge, the first analysis of age-
associated alterations to the human sperm methylome with both a global, regional, and 
CpG specific approach. While the alterations we have identified are subtle, they are 
strikingly consistent between individuals at very specific loci. As a result, the impact of 
these alterations may be of great significance to the study of transgenerational 
inheritance. A more complete knowledge of the true phenotypic impact of these 
methylation marks as well as their association with disease will be important to determine 
the role of age-associated sperm methylation alterations in the increased incidence of 
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